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 Almost 30 years ago, a fragment of DNA from Simian Virus 40 was shown to 
increase transcription of a linked rabbit β-globin gene by 200-fold (Banerji et al, 1981).  
This DNA element, termed an “enhancer” by the authors, could act at significant 
distances and independently of its orientation with respect to the promoter to drive 
augmented levels of transcription.  Although the earliest identified enhancers were 
located within viral DNA, it did not take long for investigators to draw a connection 
between the enhancer function of the SV40 sequence and the transcription-boosting 
activities of cis-regulatory sequences located near endogenous genes in species as 
evolutionarily distant as sea urchins and humans (Khoury and Gruss, 1983).  Thus began 
the study of enhancer elements and their role in transcription. 
 Enhancers were soon recognized as a critical component of transcriptional 
regulation in virtually every branch of life – bacteria, yeast, plants, invertebrates, and 
vertebrates (Guarente, 1998; Xu and Hoover, 2001; Orphanides and Reinberg, 2002).  
They were distinct from promoter elements in that their distance, orientation, and position 
relative to the transcription start site were flexible; furthermore, they were able to act on 
heterologous promoters to activate transcription (Khoury and Gruss, 1983).  Eventually, 
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it became clear that enhancers do much more than simply stimulate transcription:  they 
are capable of integrating signals from the cellular environment to control the tissue 
specificity, timing, and level of gene expression.  Thus enhancer elements are central to 
our complete understanding of transcription and gene regulation in every biological 
system. 
 
What do enhancers look like? 
 
 Eukaryotic enhancers are typically depicted as clusters of transcription factor 
binding sites located in cis to their target gene.  As might be expected, studies of 
endogenous enhancers have revealed many variations on this basic theme.  For example, 
although many enhancers are located in sequences 5’ of the promoter, enhancers are also 
frequently located downstream or even within introns of the genes they regulate.  They 
can be located very close to the promoter or tens of kilobases away.  The overall size of 
enhancers varies as well.  While most enhancers seem to range in size from several 
hundred base pairs to 1 kb, more extreme examples have been identified:  an enhancer 
that drives stripes of runt expression in the Drosophila embryo is over 5 kb in size 
(Klingler et al, 1996), while the enhancer that drives testes-specific expression of gonadal 
spans only 53 bp (Schulz et al, 1990).  Enhancers are often independent modules, in 
which each individual enhancer is responsible for generating a specific and unique 
expression pattern.  The enhancers of the even-skipped gene are a premier example of 
modularity – individual enhancers are responsible for the generation of individual 
transverse stripes of expression in the embryo (Goto et al, 1989; Harding et al, 1989; 
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Small et al, 1992).  However, sometimes regulatory information is dispersed over a broad 
region that is difficult to divide into independent modules, as in the cis-regulatory regions 
of the sea urchin endo16 gene and the Drosophila brinker gene (Yuh and Davidson, 
1996; Yao et al, 2008).   
 
Mechanisms of enhancer function 
 
 Enhancers use multiple mechanisms to regulate transcription of their target gene.  
In general, regulation of transcription is accomplished by the direct DNA-binding 
proteins that recognize specific sequences within enhancer elements and the cofactors 
with which they interact.  Enhancers can stimulate transcription by the direct recruitment 
of Pol II and the basal transcription machinery, promoting formation of the preinitiation 
complex (PIC) at the promoter (Szutorisz et al, 2005).  They can also indirectly promote 
formation of the PIC via interactions with Mediator, a huge multi-unit complex that is 
involved in recruiting and assembling the PIC at the promoter, as well as promoting 
activation of transcription (Malik and Roeder, 2005; Wang et al, 2005).  Enhancers also 
regulate transcription by influencing their local chromatin environment.  Two different 
kinds of coregulators act to modify chromatin structure:  ATP-dependent nucleosome 
remodeling complexes, such as those belonging to the SWI/SNF family; and enyzmes 
that covalently modify histones, such as histone acetyltransferases (HATs) and histone 
deacetylases (HDACs) (Narlikar et al, 2002; Orphanides and Reinberg, 2002).  Enhancers 
recruit these coregulators to bring about changes in local chromatin structure that 
promote either activation or repression of transcription.  Although chromatin 
 4 
modifications and recruitment, assembly, and stimulation of the general transcription 
machinery are all essential for the regulation of transcription, it has not yet been 
demonstrated that these mechanisms are sufficient to activate transcription.  There is 
growing evidence that enhancers act through additional mechanisms to regulate 
transcription. 
 For example, many enhancers are separated from their promoters by hundreds or 
even thousands of kilobases.  The action of activating transcription at the promoter from 
a distance represents another important aspect of enhancer function.  There are several 
proposed mechanisms for long-distance enhancer-promoter interactions (Figure 1.1):  (1) 
chromatin looping between the enhancer and the promoter; (2) tracking of the 
transcription machinery from the enhancer to the promoter; (3) facilitated tracking, a 
hybrid of the looping and tracking models, in which the transcription machinery tracks 
along the chromatin towards the promoter, and the intervening DNA between the 
enhancer and the promoter is progressively looped out; and (4) linking, in which 
facilitator proteins are recruited in a spreading fashion from the enhancer towards the 
promoter (Li et al, 2006).  There is good experimental evidence to support some of these 
models.  For instance, the looping model requires physical contact between the enhancer 
and the promoter.  Experimental techniques such as chromosome conformation capture 
(3C) allow us to detect these interactions in vivo.  Using 3C, long-range physical 
interactions between promoters and cis-regulatory elements have been observed for 
several genes, including the mouse TNF gene and the chicken β-globin locus, providing 
in vivo evidence for looping (Tolhuls et al, 2002; Tsytsykova et al, 2007).  The 









Figure 1.1.  Proposed models for remote activation of gene expression by enhancer 
elements.  In the looping model, the enhancer (blue rectangle) and the promoter (black 
rectangle) contact each other directly, perhaps mediated by enhancer and/or promoter 
binding proteins (circles), and the intervening chromatin is looped out.  In the tracking 
model, the polymerase is recruited to the enhancer and tracks along the chromatin until it 
encounters the promoter.  In the facilitated tracking model, the polymerase tracks as in 
the tracking model, and the intervening chromatin between the enhancer and the tracking 
polymerase is looped out.  Finally, in the linking model, “linking” proteins are recruited 
initially at the enhancer and then spread out towards the promoter.  Figure adapted from 
Li et al, 2006.   
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could be taken as evidence of a tracking mechanism; this phenomenon has been 
described at the human β-globin locus, as well as the Drosophila Antennapedia and 
Bithorax complexes (Gribnau et al, 2000; Bae et al, 2002; Calhoun and Levine, 2003).  
The tracking model would also predict that Pol II binding could be detected along the 
DNA between the enhancer and the promoter, an event which has been observed at the 
prostate specific antigen gene (Wang et al, 2005).  Intriguingly, that study also observed 
direct contact between the enhancer and the promoter; taken together, these data support 
the facilitated tracking model of enhancer-promoter interaction.  It remains unclear which 
mechanism most accurately describes the dynamics of distal enhancer-promoter 
interactions in vivo; perhaps there is no single “correct” model and in reality the 
mechanism differs from gene to gene. 
  
Enhancer structure and organization 
 
 All enhancers are directly regulated by sequence-specific, DNA-binding 
transcription factors, and thus the composition and organization of transcription factor 
binding sites (TFBS) are a basic aspect of enhancer structure.  The composition of TFBS 
within an enhancer often reflects the complexity of the expression pattern generated by 
that enhancer.  In most cases, a single protein is not sufficient to specify the correct level, 
timing, and location of gene expression.  For example, the Drosophila even-skipped 
stripe 2 enhancer (eve S2E), which drives expression in a single transverse stripe in the 
Drosophila embryo, contains thirteen mapped binding sites for five identified direct 
regulators (Bicoid, Hunchback, Giant, Kruppel, and Sloppy-paired 1) and is thought to be 
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regulated by at least one additional unidentified activator (Small et al, 1992; Andrioli et 
al, 2002).  Each of these regulatory inputs is required to generate the correct level and 
pattern of gene expression. 
The challenge of limiting expression to a particular time and place is particularly 
difficult for enhancers that are directly regulated by intercellular signaling pathways. 
Signaling pathways are active in many developmental contexts, but most enhancers do 
not respond universally to active signaling (Barolo and Posakony, 2002).  For example, 
the Drosophila prospero enhancer, which activates gene expression in the R7 
photoreceptors and cone cells of the eye, is directly regulated by EGFR signaling via 
direct binding of the transcription factors Pointed and Yan (Xu et al, 2000).  While EGFR 
signaling is active in many other cell types during development, including other cell types 
in the eye, the prospero enhancer does not respond in those cells (Shilo, 2003; Voas and 
Rebay, 2004).  The prospero enhancer is also directly regulated by Glass, Sine oculis, 
Lozenge, Seven-up, and the Notch effector Suppressor of Hairless (Hayashi et al, 2008).  
While each of these factors is expressed and active in cells other than R7 and cone cells, 
they act combinatorially on the prospero enhancer to direct R7- and cone cell-specific 
gene expression.  Thus the prospero enhancer, like many developmentally regulated 
enhancers, requires a combination of activators and repressors, some signal-regulated and 
others locally expressed, to provide the necessary spatial and temporal information for 
proper gene expression.  This concept – combinatorial control – is central to our 
understanding of enhancer function. 
Spatial organization is another important aspect of enhancer structure.  There are 
two current models of enhancer organization: the enhanceosome model and the 
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information display model.  In the enhanceosome model, spatial organization of binding 
sites within the enhancer is critical for the formation of a DNA-protein complex, the 
enhanceosome, and stimulation of transcription (Carey, 1998).  In these enhancers, 
changes in spacing between binding sites disrupts both DNA-protein interactions and 
protein-protein interactions, severely inhibiting transcriptional activation; cooperative 
binding and synergistic activation are key components of enhanceosome function.  There 
are several classic examples of enhanceosome-style enhancers, including the IFNβ and 
TCRα enhancers, in which binding site spacing must obey strict organizational rules 
(Giese et al, 1995; Thanos and Maniatis, 1995).  An opposing model of enhancer 
structure, the information display model, proposes that these enhanceosomes are the 
exception rather than the rule, and that spatial organization of TFBS is quite flexible in 
most enhancers (Arnosti and Kulkarni, 2005).  In an information display enhancer, 
individual activators and repressors do not require cooperativity for either their DNA-
binding or regulatory properties, and therefore their binding sites can be rearranged along 
the DNA without affecting enhancer function.  This model also suggests that the 
transcriptional output generated by the enhancer is essentially the integrated sum of 
activating and repressive inputs binding to the enhancer at any given moment.  The eve 
S2E is considered to be an information display enhancer.  Mutated eve S2E constructs 
can be rescued by the addition of novel activator sites, suggesting that the location of 
activator binding sites within the enhancer is flexible (Arnosti et al, 1996).  Evolutionary 
comparisons also suggest flexibility in TFBS position within eve S2E.  Although the 
function of the eve S2E is conserved throughout Drosophilids and even Sepsids, 
alignments reveal that the arrangement of TFBS within these enhancers varies 
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considerably, in support of organizational flexibility (Ludwig et al, 1998; Hare et al, 
2008).  Furthermore, the level of gene expression generated by eve S2E can be 
manipulated in vivo by changing the affinity of activator binding sites or altering 
activator concentration, which supports the model’s prediction that transcriptional output 
represents the sum of individual regulatory inputs (Arnosti et al, 1996).   
Both the enhanceosome and information display models appear to accurately 
describe several characterized enhancer elements.  However, in many cases the overall 
structure of the enhancer is not as strict as an enhanceosome, but not entirely flexible 
either.  For example,  in synthetic constructs containing binding sites for the repressor 
Giant and the activator Gal4, binding site organization dramatically affected the ability of 
Giant to repress transcriptional activation (Kulkarni and Arnosti, 2005).  Although these 
constructs were unlikely to be behaving as enhanceosomes, organization was clearly 
important for interactions between Giant and Gal4, suggesting that short-range repression 
is sensitive to changes in spacing and organization of repressor and activator sites.  In 
addition, many activators interact synergistically to activate transcription, implying that 
binding sites for those proteins would be sensitive to spatial organization as well; for 
example, synergistic activation of proneural gene expression by Suppressor of Hairless 
and Daughterless requires certain binding site configurations in Drosophila (Cave et al, 
2005).  These local interactions can be thought of as subelements within the overall 
enhancer structure.  Refinement of the information display model to include subelements 
as well as individual TFBS can accurately explain the nature of many enhancers. 
However, there is still uncertainty in assigning enhancers to either one model or 
the other.  For example, a set of neuroectoderm enhancers in Drosophila share a common 
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set of regulatory motifs with characteristic spacing and organization (Erives and Levine, 
2004).  Furthermore, these structural characteristics appear to be conserved from 
Drosophila to Anopheles, indicating that the sequences, positions, and orientations of 
these motifs are inflexible.  While the DNA-binding proteins regulating these enhancers 
interact synergistically, it is not clear that an enhanceosome-type complex assembles on 
these enhancers (Shirokawa and Courey, 1997; Bhaskar and Courey, 2002).  Clearly 
there is significant restraint on the organization of these enhancers, but can they truly be 
labeled as enhanceosomes?  At this point, our knowledge of enhancer structure is 
incomplete, making it difficult to know how to classify enhancers that fall on the 
spectrum between enhanceosome and information display.  More examples and further 
experiments are required before these questions can be answered. 
  
Unanswered questions in the field 
 
 We’ve come a long way towards understanding enhancer elements and their role 
in transcriptional regulation in the last 30 years.  Yet many questions remain:  How does 
the enhancer interact with the promoter at great distances?  What is the function of 
noncoding transcription arising from the enhancer?  How are enhancers involved in 
subnuclear localization of chromatin?  How do enhancer sequences evolve?  These are all 
big questions that are currently being addressed.  More surprisingly, our grasp of even the 
most basic aspects of enhancer function is shaky:  What are the basic, necessary 
components required to build a functional enhancer?  What are the rules of enhancer 
organization?   
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 As we understand it, transcription factor binding sites are the critical components 
of enhancers; TFBS recruit transcription factors, which go on to recruit cofactors that 
stimulate transcription through a variety of mechanisms.  This seems very 
straightforward, and if true, we should be able to build synthetic versions of enhancers 
composed of only their TFBS.  Unfortunately, this type of in vivo proof-of-principle 
experiment is rarely attempted for endogenous enhancers.  In the few reported cases 
where this concept has been experimentally tested in vivo – for example, the well-
characterized Drosophila enhancer of split m4  proneural and short gastrulation 
neuroectoderm enhancers – the synthetic enhancers fail to recapitulate endogenous 
expression patterns (Johnson et al, 2008; Liberman and Stathopoulos, 2009).  Of course, 
there are many reasons why these experiments might fail; these synthetic constructs may 
lack critical binding sites that have not yet been identified, or the synthetic constructs 
violate important spatial or organizational rules.  However, our incomplete understanding 
of the basic composition and structure of even the best studied enhancers points out 
significant gaps in our knowledge.   
 Currently, no single enhancer has truly been completely characterized.  Even the 
eve stripe 2 enhancer remains unsolved; deletions of any of the sequences that do not 
contain mapped binding sites significantly reduces enhancer function, and it is unknown 
whether those sequences are important because they harbor novel binding sites or 
because they preserve the spacing between adjacent sites (Andrioli et al, 2002).  Without 
an enhancer in which all the essential regulatory sequences are identified, we are unable 
to proceed to the next steps of experimentation.  Thus important questions remain 
unanswered, and we are hampered in our attempts to identify cis-regulatory elements in 
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silico, predict enhancer function based on TFBS composition and organization, or build 
enhancers that drive a desired pattern of gene expression.  
 The objective of this thesis research was to perform an in-depth, in vivo structure-
function analysis of an endogenous enhancer.  Our goal was to map all the critical 
regulatory sequences within a single enhancer, and to begin to understand the structural 
rules that govern enhancer function.  My approaches included in vivo mutagenesis of 
enhancer sequences, construction of synthetic enhancers, evolutionary analysis of 
enhancer sequence and structure, and biochemical identification of novel enhancer-
binding proteins, all using a signal-regulated enhancer from Drosophila as our model for 
an endogenous, tissue-specific enhancer. 
 
The D-Pax2 sparkling enhancer 
 
 We selected the D-Pax2 sparkling enhancer for our studies.  The sparkling (spa) 
enhancer regulates expression of D-Pax2 in the Drosophila eye, an excellent system for 
studying intercellular signaling and cell fate specification.  Furthermore, previous 
characterization of spa provided a starting point for continued investigation. 
 The Drosophila eye is composed of approximately 750 repeating units called 
ommatidia (Figure 1.2A, Voas and Rebay, 2004).  Each ommatidium contains 8 
photoreceptors (R1-8), 4 cone cells, 2 primary pigment cells, 6 secondary pigment cells, 
3 tertiary pigment cells, and 3 bristle cells (Figure 1.2C).  Differentiation of the eye field 





Figure 1.2.  Drosophila eye development.  (A)  SEM image of a Drosophila eye, which 
is composed of repeating honeycomb-shaped units called ommatidia.  (B)   Third instar 
larval eye-antennal imaginal disc.  The arrow marks the position of the morphogenetic 
furrow, which sweeps across the eye disc from the posterior (left) to the anterior (right).  
The cells posterior to the furrow are undergoing differentiation; here, those cells that have 
been specified as photoreceptors are stained.  (C)  A single pupal ommatidium, with cell 
types labeled: C = cone cells, 1° = primary pigment cells, 2° = secondary pigment cells, 
3° = tertiary pigment cells, B = bristle cells.  At this stage, photoreceptors are located in a 
different plane of focus, and therefore cannot be seen in this image.  (D) Diagram of the 
sequential recruitment of cells into ommatidia behind the morphogenetic furrow (MF), 
which is progressing from left to right in this figure.  Cells are recruited from a pool of 
undifferentiated precursors (orange cells at bottom) in a stereotypical order: 
photoreceptors R8, R2, R3, R4, and R5 are recruited first, followed by R1, R6, and R7, 
then the cone cells, and finally the pigment cells.  Adapted from  Nagaraj and Banerjee, 
2004; and Voas and Rebay, 2004. 
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initiated by Decapentaplegic (Dpp) and Hedgehog (Hh) signaling at the morphogenetic 
furrow (Figure 1.2B, Silver and Rebay, 2005).  As the morphogenetic furrow passes 
along the eye disc from the posterior to the anterior, the cells posterior to the furrow are 
sequentially recruited into ommatidia (Figure 1.2B, D).  The order of specification and 
recruitment is fixed (Figure 1.2D).  The R8 cells are specified first by Notch-mediated 
lateral inhibition, and they become the founder cells for each ommatidium.  Specification 
of R8 is followed by recruitment and specification of R2 and R5, R3 and R4, R1 and R6, 
R7, the cone cells, and finally the primary, secondary, and tertiary pigment cells.  The 
sequential specification of these cell types is regulated by the EGFR and Notch signaling 
pathways.  Interestingly, both EGFR and Notch are required for the specification of 
multiple cell types during eye differentiation, and thus these two signals alone are not 
sufficient to specify unique cell fates in the eye.  EGFR and Notch must act 
combinatorially with locally expressed activators and repressors to activate expression of 
the target genes that determine cell fate. 
 The D-Pax2 gene is one of the EGFR/Notch target genes that is responsible for 
determining cell fate in the eye; its expression in cone cells is necessary for their proper 
fate specification (Fu and Noll, 1997).  Cone cell-specific expression is controlled by an 
enhancer located in the fourth intron of the D-Pax2 gene, the sparkling (spa) enhancer 
(Figure 1.3, Fu et al, 1998).  Further characterization of spa identified a 362 bp minimal 
element sufficient for cone cell-specific gene expression, and furthermore mapped the 
location of twelve TFBS within this minimal enhancer (Flores et al, 2000).  The twelve 
TFBS included binding sites for three distinct regulatory inputs (Figure 1.3C).  First, spa 







Figure 1.3.  The D-Pax2 sparkling enhancer.  (A-B) D-Pax2 is expressed in cone cells  
of third instar larval eye imaginal discs.  (A) A third instar larval eye-antennal imaginal 
disc, oriented with posterior to the bottom, is stained with anti-D-Pax2 antibody; MF = 
morphogenetic furrow. (B) Higher magnification image shows that all four cone cells in 
each ommatidium express D-Pax2; circle outlines a single ommatidium.  (C) Model of 
the sparkling enhancer, which regulates expression of D-Pax2 in the cone cells.  
Sparkling is directly regulated by Notch signaling, EGFR signaling, and Lozenge.  SME 
= sparkling minimal enhancer.  (D) The SME, placed upstream of a LacZ reporter, is 
sufficient for cone cell-specific gene expression.  Adapted from Fu and Noll, 1997; and 
Flores et al, 2000. 
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undifferentiated progenitor cells posterior of the morphogenetic furrow (Flores et al, 
1998).  Second, spa contains binding sites for the transcriptional effector of the Notch 
signaling pathway, Suppressor of Hairless (Su(H)).  Su(H) acts as a transcriptional 
switch; in the absence of active Notch signaling, it mediates repression of target gene 
expression, but in the presence of active signaling, it functions as a transcriptional 
activator (Bray, 2006).  Finally, spa also contains Ets binding sites, which are directly 
bound by both PointedP2 (Pnt) and Yan, effectors of the EGFR/MAPK signaling 
pathway.  Pnt and Yan bind to the same sites, but Pnt mediates activation through those 
sites while Yan mediates repression.  In the absence of EGFR signaling, Yan represses 
target genes, while in the presence of active EGFR signaling, Pnt is phosphorylated and 
activates target genes (Brunner et al, 1994; O’Neill et al, 1994; Rebay and Rubin, 1995).  
Both genetic manipulations and in vivo binding site mutations demonstrated that spa 
requires each of these regulatory inputs for proper regulation of D-Pax2 expression. 
  Theoretically, it was possible that the characterized regulatory inputs, acting 
combinatorially, might be sufficient to dictate cone cell-specific activation of the spa 
enhancer.  Furthermore, the additive effects of twelve activators bound to spa in putative 
cone cells could provide sufficient activation to generate proper levels of gene 
expression.  Because knowledge of the regulation and TFBS composition of spa was 
potentially complete, we thought the spa enhancer would be a perfect candidate for this 
thesis project.  Therefore, in my thesis, I used the D-Pax2 sparkling enhancer as a model 









STRUCTURAL RULES AND COMPLEX REGULATORY CIRCUITRY 





Enhancers, or cis-regulatory elements, are the primary determinants of 
spatiotemporal patterns of gene expression.  In order to properly regulate their target 
genes, enhancers must perform a number of functions, such as identifying and 
communicating with the promoter, sometimes over great distances, and triggering 
transcription in certain cells, but not in others.  Many enhancers are capable of driving a 
heterologous promoter in the proper pattern when removed from their normal genomic 
context.  This autonomy implies that enhancers can assemble a complete set of 
biochemical activities that together are sufficient for robust, patterned transcriptional 
activation at a remote promoter.  Do different DNA-binding factors recruit distinct types 
of activation activities, or must the enhancer merely accumulate enough of a single, 
limiting activity to exceed a threshold for activation? 
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 Different types of studies reach widely divergent conclusions about enhancer 
complexity.  For example, Eric Davidson and colleagues, combining reporter assays with 
affinity purification in an extensive study of cis-regulatory logic in the sea urchin Endo16 
gene, identified 55 binding sites for 16 regulatory proteins, which form an intricate 
regulatory computer spanning 2300 bp of DNA (Davidson, 1999).  On the other hand, 
most developmental genetics-based enhancer studies culminate in models requiring no 
more than three to five different regulators (often only one or two), binding within ~300-
1000 bp of DNA, to explain the activity and specificity of a seemingly typical enhancer.  
In the very rare cases where the question of sufficiency is addressed in vivo, the defined 
regulatory sites are generally insufficient to properly reconstitute enhancer function, and 
an unknown activator “X” is added to the model (reviewed by Barolo and Posakony, 
2002).  How many cis-regulatory sites are sufficient, when combined, to recapitulate 
normal enhancer function, in the context of a chromosome in a normal cell? 
 We have pursued a bottom-up approach to these questions by taking a previously 
well-characterized developmental enhancer and exhaustively dissecting it in vivo, both to 
discover the extent of its regulatory complexity and to determine whether different 
enhancer sub-elements perform distinct functions.  We chose to study the sparkling (spa) 
enhancer of the dPax2 gene, which is necessary and sufficient to specify the cone cell 
fate in certain multipotent cells in the developing Drosophila eye (Fu and Noll, 1997; Fu 
et al., 1998; Flores et al., 2000; Shi and Noll, 2009).  spa drives cone cell-specific dPax2 
expression in response to four direct regulators, acting through twelve transcription factor 
binding sites (TFBSs): Suppressor of Hairless [Su(H)], under the control of Notch 
signaling; two Ets factors, the activator PointedP2 (Pnt) and the repressor Yan, both 
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controlled by EGFR/Ras/MAPK signaling; and the Runx-family protein Lozenge (Lz) 
(Fu et al., 1998; Flores et al., 2000; Tsuda et al., 2002) (Figure 2.1A).  In their report 
describing the direct regulation of the spa enhancer by Su(H), Lz, and Ets factors, Flores 
et al. (2000) proposed a model in which a combinatorial code, Lz + EGFR/Pnt/Yan + 
Notch/Su(H), determines the cell type specificity of spa activity.  The authors were 
careful to state that “the model…reflects requirements rather than sufficiency for cell fate 
specification.”  Despite this caveat, the Lz+Ets+Su(H) code is now considered to  “define 
the combinatorial input required for cone cell specification” (Voas and Rebay, 2004; see 
also Pickup et al., 2009; Shi and Noll, 2009). 
 Because the spa enhancer is small (362 bp), and because the known regulatory 
inputs could, in theory, explain its cell-type specificity (Flores et al., 2000), we 
considered it an ideal test case for a comprehensive structure-function analysis.  Here, we 
report the results of our initial tests, which reveal several surprising aspects of spa 




For our in vivo analysis of the spa enhancer, we used a specially built Gateway 
reporter transgene vector, Ganesh-G1, in which enhancers are placed upstream of a 
minimal, TATA-containing promoter taken from the Drosophila Hsp70 gene, driving an 
EGFP-NLS reporter (Swanson et al., 2008).  A unique feature of this vector is that the 
enhancer is placed 846 bp upstream from the transcription start site (Figure 2.1A).  Thus, 





Figure 2.1.   The known regulators of spa are insufficient for transcription in cone cells.  
(A)  Summary of the known regulatory inputs of the sparkling (spa) cone cell enhancer 
of D-Pax2.  Defined TF binding sites (TFBSs) are shown as colored bars; 
uncharacterized sequences are gray.  The enhancer is placed 846 bp upstream of the 
transcription start site in all transgenic constructs, except those in Figure 2.4.  (B-D) 
Expression of a GFP transgene under the control of spa.  (B) Eye-antennal imaginal disc 
from a spa-GFP transgenic larva.  (C) The posterior of an eye disc, corresponding 
approximately to the boxed area in (B).  Posterior is to the top.  (D) Eye of a 24-hour 
pupa carrying spa(wt)-GFP, stained with antibodies against GFP (green) and the cone 
cell nuclear marker Cut (magenta).  (E) spa(synthNS), in which the previously 
uncharacterized sequences have been altered (black), but the 12 defined TFBSs are 
present in their native arrangement and spacing, fails to drive gene expression.  (F) 
spa(synthCS), containing the 12 TFBSs in compressed spacing, is active in a few cells at 
the posterior margin, but does not recapitulate the cone cell activity of spa(wt). 
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moderate distance from the promoter.  We do not consider this an unfair test of enhancer 
activity, given that, in its native genomic context, the dPax2 spa enhancer is located >7 
kb from its promoter (Fu et al., 1998).  We generated at least 4 independent transgenic 
lines for each reporter construct.  Because line-to-line variability was generally low, we 
found that examination of 3-5 independently derived lines was sufficient for most 
constructs.  For constructs with more variable expression (usually those with low 
activity), we examined additional lines (10-14) to ensure that our conclusions were not 
based on rare insertion effects.   
When placed in Ganesh-G1, spa drives cone cell-specific GFP expression in 
developing retinas of transgenic larvae and pupae (Figures 2.1B-2.1D).  This and 
previous work by Flores et al. (2000) demonstrate that the 362-bp spa enhancer contains 
all sequences necessary to (1) activate gene expression in vivo and (2) restrict this 
activation to developing cone cells. 
 
The [Lz + Pnt + Su(H)] code is insufficient to specify cone cell expression 
 
All three of the known positive regulators of the spa enhancer are required for its 
activity and cone cell specificity.  This suggested a “combinatorial code” model for 
dPax2 regulation, in which the combined activities of Lz, Pnt, and Su(H), acting through 
binding sites in spa, cooperatively activate dPax2 expression specifically in cone cells 
(Flores at al., 2000; Tsuda et al., 2002; Nagaraj and Banerjee, 2007).  We began our 
analysis by testing the simplest form of such a model, which predicts that the binding 
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sites within spa that mediate those three regulatory inputs should suffice, in combination, 
to drive gene expression in cone cells. 
 First, we built a synthetic spa enhancer construct in which all twelve of the 
defined binding sites for Lz, Su(H), and Pnt/Yan within spa are intact (along with 3-4 
flanking base pairs to either side), and are placed in their native arrangement and 
spacing—but in which all other enhancer sequences are mutated by altering every second 
base pair.  This construct, called spa(synthNS) because of the native spacing of its TFBSs, 
fails to activate gene expression in vivo (Figure 2.1E).  A second version of spa(synthNS), 
in which the opposite set of base pairs was mutated, produced the same result (not 
shown).  We also created spa(synthCS), a compressed-spacing construct containing the 
same twelve sites, in which inter-site sequences of >12 bp have been reduced to 12 bp.  
spa(synthCS) also fails to act as a cone cell enhancer, although weak GFP expression can 
be detected in a few non-cone cells (Figures 2.1F, 2.5H; Table S2.1).   Based on these 
findings, we hypothesized that additional sequences, besides the twelve defined 
regulatory sites, are necessary for proper transcriptional regulation mediated by spa. 
 
Multiple novel sites within spa are required for cone cell activation 
 
In order to pinpoint the novel regulatory sequences within spa that make essential 
contributions to enhancer activity in vivo, we conducted a systematic mutational analysis 
of all previously uncharacterized sequences within spa.  These sequences were divided 
into regions 1 through 6, and each region was deleted in turn, leaving the known TFBSs 












Figure 2.2.  Sequence and/or spacing rules apply to multiple segments of spa.  (A) 
Diagrams of spa enhancer constructs and summary of their cone cell activity in larval eye 
discs.  Dotted lines indicate deletions; black bars indicated mutations that preserve native 
spacing (NS).  In each case, the 12 known TFBSs are preserved.  +++, wild-type levels 
and pattern of expression in cone cells; ++, moderately reduced; +, severely reduced; +/, 
detectable in very few cells; -, no detectable expression; ++++, augmented levels of 
expression.  (B-K) GFP expression in eye imaginal discs driven by the wild-type spa 
enhancer (B) and mutant enhancers (C-K) carrying deletions or NS mutations in 
previously uncharacterized sequences, numbered 1 through 6. 
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makes no significant contribution to cone cell expression.  Deleting regions 1, 2, 4, or 6 
causes total or near-total loss of gene expression in vivo; conversely, deleting region 5 
enhances expression in cone cells (Figures 2.2A-2.2G). 
 
Spacing vs. sequence 
 
Internal deletions of enhancer DNA cause two simultaneous changes: loss of the 
deleted sequence, and altered relative spacing of the sites to either side.  To distinguish 
between these two types of effects, we made native-spacing (NS) mutations in which a 
specific sequence was altered, but its length was preserved.  In regions 4 and 6, native-
spacing alterations and deletions have similar effects, indicating that the sequence content 
of these regions is functionally significant (Figures 2.2D, 2.2G, 2.2H, and 2.2K).  
However, a native-spacing mutation in region 2 has a less severe effect than a deletion 
(Figure 2.2H; cf. Figure 2.2D), from which we infer that much of the regulatory 
contribution of region 2 can be attributed to its length, rather than its sequence.   
 Within region 5, deleting the DNA and altering its sequence have opposing 
effects.  Deleting region 5 augments cone cell expression, while a native-spacing 
mutation causes a severe loss of activity (Figures 2.2F and 2.2J).  The simplest 
interpretation of these results is that region 5 harbors positive regulatory sequences that 
are normally required, but that the deletion brings together sites on either side of region 5, 
increasing synergy between TFs and thus compensating for the loss of regulators 
normally binding to region 5.  Consistent with this interpretation is the fact that Pnt and 
Lz, which bind to either side of region 5, physically interact and synergistically activate 
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transcription, as can mammalian orthologs of these factors (Flores et al., 2000; Behan et 
al., 2005 and references therein).  The fact that multiple smaller-scale NS mutations 
within region 5 impair spa function, while none augment expression (see Figure 2.3), 
further supports this conclusion. 
 
spa is densely packed with regulatory sites 
 
The above analysis demonstrates that, in addition to the defined TFBSs, regions 1, 
4, 5, and 6 of spa (and to a lesser extent region 2) are essential for its proper function.  
Each of these segments is large enough to contain several protein binding sites of typical 
size.  To determine what proportion of these sequences has a regulatory role, we made 
native-spacing mutations to smaller segments (10 bp, on average) within regions 1, 4, 5, 
and 6.  Of these 12 finer-scale mutations, ten cause severe or total loss of gene expression 
in cone cells (Figure 2.3).  In addition, further experiments described below indicate the 
presence of novel repressive regulatory site(s) within spa, but outside of regions 1/4/5/6.   
Given that the consensus binding sites for the known regulators of spa are <9 bp in 
length, there is room for many regulatory sites within these regions.  Together, the novel 
regulatory sites described here and the previously described TFBSs densely populate spa, 
with apparent “junk” or “spacer” sequences constituting a small proportion of the 
enhancer. 
 To investigate the possibility that the regulatory sites in regions 1, 4, 5, and 6 act 
by facilitating binding of the known activators to nearby binding sites, and the related 







Figure 2.3.  Most of spa is composed of critical regulatory sequences.  (A-E) Diagrams  
of mutated spa enhancer constructs.  Blue, yellow, and red bars indicate defined binding 
sites for Lz, Pnt/Yan, and Su(H), respectively.  Dotted lines indicate deletions; black bars 
indicate mutations that preserve native spacing (NS).  GFP expression in larval cone cells 
is summarized as in Figure 2.2. 
 27 
activators, we tested the ability of Lz and Su(H) to bind to sites within spa in vitro.  In all 
cases, mutating essential novel regulatory sequences did not significantly reduce the 
affinity of Lz or Su(H) for nearby binding sites, as determined by EMSA competition 
experiments (Table S2.2).  Pnt does not bind in vitro to any sites flanking regions 1, 4, 5, 
or 6 (Flores et al., 2000).  Therefore, in subsequent experiments we pursued the 
possibility that these regions of spa have novel functions, other than direct recruitment of 
the known activators. 
 
Evidence for a new type of regulatory site, specifically mediating action at a distance 
 
The mutational analysis described above defined many novel regulatory sites of 
equal importance to the known Lz+Ets+Su(H) sites.  We next attempted to isolate and 
study an important but poorly understood function of the enhancer: activation at a 
distance.  As mentioned above, all of the enhancer constructs described thus far were 
placed 846 bp upstream of the promoter, thus forcing them to act over a moderate 
distance.  If we could rescue the activity of a mutant enhancer by moving it close to the 
promoter, we reasoned, the mutated region is likely to specifically mediate remote 
enhancer-promoter interactions.  Conversely, if a mutation cannot be rescued by 
promoter-proximal placement, it is likely to mediate a different step in gene activation.  
 The wild-type spa enhancer drives the same pattern from -121 bp as from -846 bp 
(Figure 2.4A), although activation is noticeably more robust from the more proximal 
position.  A mutant spa enhancer lacking region 1 [spa(∆1)], which is transcriptionally 






Figure 2.4.  Region 1 is required for activation at a distance, but not for patterning.  (A-
E) Transgenic larval eye discs.  In this figure, all enhancers are proximal to the minimal 
Hsp70 promoter, at position -121 from the transcription start site, compared to -846 in all 
other figures.  Because spa drives stronger expression from a promoter-proximal 
position, images are collected at a lower exposure than in other figures.  (A) spa(wt) 
drives strong cone cell expression from -121 bp.  (B) spa(∆1), which is inactive when 
distant from the promoter (cf. Figure 2.2C), drives strong expression in the proper pattern 
from a promoter-proximal position.  (C-E) In contrast to region 1, spa regions 4, 5, and 
6a are required for wild-type levels of cone cell expression at both distal and proximal 
positions (cf. Figure 2.2I-K). 
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driving robust gene expression in the normal pattern (Figure 2.4B).  By contrast, 
enhancers with mutations in regions 4, 5, or 6a remain unable to drive wild-type levels or 
patterns of gene expression at -121 (Figures 2.4C-2.4E).  Interestingly, each of these 
constructs partially recovers cone-cell activity by mid-pupal stages (not shown), 
suggesting that these regions may be more critical for initiation than for maintenance of 
gene expression.  Similarly, Lz, Pnt, and Su(H) binding sites are required even when spa 
is promoter-proximal (Flores et al., 2000).  Of all regulatory sites within spa, only region 
1 is both dispensable for enhancer activity and patterning in a promoter-proximal 
position, and essential for activation at a distance. 
 To our knowledge, this is the first case of a regulatory element found within an 
enhancer that specifically mediates action from a remote position, with no apparent role 
in patterning of gene expression or other basic activation functions (see Discussion).  We 
therefore refer to region 1 as a “remote control” element to functionally distinguish it 
from patterning elements within spa, which include the defined TFBSs as well as new 
patterning sites to be discussed below.  Future experiments will test the range, potential 
promoter preferences, and functional properties of this unique regulatory element. 
 
Unlike the known TFs, Region 1 acts independently of its position within spa  
 
Having mapped all essential regulatory sites within spa, we could then ask 
whether their linear organization influences gene expression in vivo.  First, we tested the 
structural flexibility of region 1, the remote control element (RCE), by moving it from the 
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5’ end to the 3’ end of the enhancer.  This rearranged enhancer performs normally at -846 
bp (Figure 2.5G), which indicates that the precise position of the RCE, relative to the 
other regulatory sites within spa, is not a critical factor in its remote activation function.  
Future experiments will determine the distance, relative to the enhancer and to the 
promoter, over which the RCE can act. 
 By contrast, the Lz/Ets/Su(H) binding sites show strong position dependence.  We 
rearranged these sites within spa by moving each TFBS (along with flanking sequences) 
to the position of another, randomly chosen, TFBS.  The resultant construct, spa(TF 
scrambled), is only weakly active in cone cells (Figure 2.5G).  Thus, unsurprisingly but in 
contrast to the RCE, the configuration of the known TFBSs within spa plays an important 
role in enhancer function in cone cells. 
 
Cell type specificity is controlled by the structural organization of spa 
 
The diminished activity of spa(TF scrambled), along with the altered gene 
expression resulting from deletions in regions 2 and 5, suggest that the spatial 
organization of spa impacts its transcriptional activity.  We next took a different approach 
to investigate the relationship between structure and function within spa. 
 As we have demonstrated, the 12 defined TFBSs within spa are insufficient for 
cone cell enhancer activity, even when combined.  Likewise, when these TFBSs are 
mutated, the remaining sequences are incapable of driving transcription [spa(KO), Figure 
2.5B].  Since these two constructs, taken together, include all sequences from spa, we 




Figure 2.5.  Cell-type specificity of spa is controlled by the arrangement of its regulatory 
sites.  (A-D) GFP expression driven by spa enhancer constructs in larval eye discs.  All 
constructs shown here are at the -846 position.  (B) spa(KO), in which all 12 Lz/Ets/Su(H) 
sites are mutated, is inactive.  (C) A rearranged version of spa, in which spa(KO) is placed 
next to the 12 TFBSs to create spa(KO+synthCS), drives robust gene expression, but in a non-
cone-cell pattern.  (D) Combining spa(KO) with spa(synthNS) fails to drive gene expression, 
though all sequences from spa are present.(E and F) spa(KO+ synthCS) is expressed 
specifically in photoreceptors (PRs), but not in cone cells, in 24-hour pupae.  (E) Confocal 
images at two different planes, in retinas stained with antibodies against GFP (green) and the 
cone cell nuclear marker Cut (magenta), show GFP in two nuclei per ommatidium, located 
basally to cone cells.  Posterior is to the top. (F) GFP driven by spa(KO+ synthCS) co-
localizes with the PR marker Elav (red).  (G-J) Organization of regulatory elements within 
spa is critical for both transcriptional activity and cell-type specificity.  (G) Transferring 
region 1 from the 5’ to the 3’ end of spa does not impair its function in long-range 
transcriptional activation (∆1+1).  In contrast, randomizing the positions of the 12 
Lz/Ets/Su(H) binding sites within spa(TF scrambled) impairs its activity in cone cells, with 
no ectopic activity in other cell types.  (H) Rearranging the regulatory sites of spa converts its 
cell-type specificity.  (I) Combining the defined TFBSs with novel regions 1, 4, and 6a drives 
strong R1/R6 expression.  This depends on Lz and Ets sites and region 4, but not Su(H) sites.  
(J) 2X synthCS, containing two copies of every known TFBS, is inactive in cone cells, with 
moderate ectopic PR activity.  2X synthNS is inactive in all cell types.  (K) Region 5 of spa 
mediates repression in PRs, as well as activation in cone cells.  spa(m2,3,6bNS), a native-
spacing spa construct in which regions 2, 3, and 6v are mutated, drives normal (i.e., cone 
cell-specific) gene expression.  Further mutating region 5 causes a switch from cone cell-
specific to PR-specific gene expression. 
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rearranged spa construct, KO+synthCS, drives strong gene expression in the eye (Figure 
2.5C). 
 Three aspects of this finding are worth noting.  First, the activity driven by 
KO+synthCS is robust, exceeding spa(wt) in intensity (Figure 2.5C; cf. panel A).  The 
defined TFBSs, therefore, are capable of acting synergistically with novel activator sites 
in spa, even when the enhancer is reconfigured.  This, combined with our in vitro binding 
data mentioned above, strongly suggests that the new regulatory sequences are not 
merely extended binding sequences for Lz/Pnt/Su(H). 
 Second, when the TFBSs adjacent to spa(KO) are spread out to mimic their native 
spacing, gene expression is lost (KO+synthNS, Figure 2.5D).  The activity of spa is 
apparently highly dependent on close proximity, among the known TFs and/or between 
those TFs and novel regulators.  Since KO+synthCS and KO+synthNS differ by only 29% 
in total length, and because KO+synthNS, at 730 bp, is not large compared to many 
enhancers, this extreme dependence on short-range interactions was surprising. 
 Third, and most importantly, the pattern of gene expression driven by the 
rearranged enhancer spa(KO+synthCS) differs from that of spa(wt)—in fact, the two 
elements drive completely non-overlapping expression patterns.  Unlike spa(wt), whose 
activity co-localizes with the cone cell marker protein Cut (Figure 2.1D), KO+synthCS-
GFP is expressed only in nuclei located basally to Cut+ cells (Figure 2.5E).  KO+synthCS 
is active in a subset of basal cells expressing Elav, a marker of photoreceptor cell fate 
(Robinow and White, 1988).  Based on the position of the two GFP+ cells within the 
Elav+ photoreceptor cluster, spa(KO+synthCS)’s activity is restricted to photoreceptors 1 
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and 6 (R1/R6) (Figure 2.5F).  Thus, merely re-arranging the regulatory sites within spa is 
sufficient to cleanly switch its cell-type specificity in vivo. 
 
Ectopic photoreceptor-specific transcription depends on Lz and Ets binding sites, 
additional novel regulatory sequences, and tight clustering of regulatory sites 
 
We next attempted to identify the regulatory sites responsible for ectopic activity 
of spa in photoreceptors (PRs).  Combining regions 1, 4, and 6a with the known TFBSs 
(1+4+6a+synthCS) results in strong R1/R6 expression; removing region 4 from this 
construct weakens its activity (Figure 2.5I).  By selectively mutating TFBSs, we found 
that R1/R6 expression requires Lz and Ets sites, but not Su(H) sites (Figure 2.5I).  This is 
consistent with the fact that R1/R6 receive MAPK signaling and express Lz at high 
levels, but do not respond to Notch signaling (reviewed by Voas and Rebay, 2004). 
 Based on our remote vs. proximal enhancer analysis (Figure 2.4), we 
hypothesized that different regulatory sequences within spa contribute distinct activities 
to gene activation.  If this is so, one type of activity may not be able to functionally 
substitute for another. We tested this idea by creating tandem repeats of the synthCS and 
synthNS constructs, which contain two copies of each known TFBS, in compressed or 
native spacing, respectively.  2XsynthCS is inactive in cone cells and relatively weakly 
active in PRs, while 2XsynthNS is inactive in all cell types (Figure 2.5J).  We therefore 
conclude that the Lz+Ets+Su(H) combination is insufficient for cone cell activation.  
Further, the fact that additional Lz/Ets/Su(H) sites fail to compensate for the missing 
novel regulatory sites adds support to the idea that some parts of the enhancer perform 
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functions in transcriptional activation that are qualitatively distinct from those of the 
known regulators. 
 Interestingly, when spa(synthNS) is placed at -121 bp, we observe occasional 
position-effect-dependent activity in cone cells (1 out of 7 lines) or PRs (1 of 7 lines) 
(Figure S3).  The pattern of gene expression in these two lines depends on the site of 
transgene insertion, which is consistent with the conclusion that Lz+Ets+Su(H) can 
contribute to gene expression in multiple cell types, but only in combination with 
additional regulatory inputs. 
 
A novel, short-range, cell type-specific repressor activity prevents spa activation in 
photoreceptors 
 
In both spa constructs driving strong ectopic R1/R6 activity, spa(KO+synthCS) 
and spa (1+4+6a+synthCS), the configuration of defined TFBSs differs from wild-type in 
two respects: their spacing relative to one another is reduced, and their linear order and 
position relative to the novel regulatory sequences is altered.  Ectopic photoreceptor 
expression, then, could have three possible (non-exclusive) causes: (1) tight TF clustering 
may increase synergy by Lz and Pnt in R1/R6, or altered spacing between TFs and novel 
sites may cause (2) inappropriate synergistic activation and/or (3) weakened repressive 
interactions in PRs.  In order to test these models, and to further explore the role of 
enhancer structure, we generated compound mutations in multiple regions of spa, while 
keeping the spacing/arrangement of the remaining sequences intact. 
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 First, we simultaneously mutated regions 2, 3, and 6b of spa, none of which are 
essential for cone cell expression.  This construct, spa(m2,3,6bNS), is comparable to 
spa(wt) in its pattern and levels of expression (Figure 2.5K).   Next, we additionally 
mutated region 5 in this construct to create spa(m2,3,5,6bNS).  Remember that when 
region 5 alone is mutated, cone cell expression is severely reduced, and no ectopic 
expression is seen (Figures 2.2J and 2.3D).  However, when region 5 is mutated 
simultaneously with 2/3/6b, a discrete switch from cone cell- to R1/R6-specific 
expression occurs (Figure 2.5K).  Therefore, region 5 mediates repression in PRs, in 
addition to activation in cone cells.  This repressive activity must be redundant with 
additional repressor site(s) in regions 2/3/6b.  It must also have a very limited range of 
action, since moving Lz and Ets sites to the 3’ end of the enhancer, without altering the 
repressor sites (KO+synthCS), de-represses spa in R1/R6.  
 
spa enhancer evolution: function is conserved despite rapid turnover of regulatory 
sequences 
 
Taking this study and previous work into account, spa is among the most finely 
mapped enhancers with respect to regulatory sites essential for function in vivo.  We 
made use of the recent sequencing of multiple Drosophila species genomes (Drosophila 
12 Genomes Consortium, 2007) to investigate the evolutionary history of spa.  We will 
focus on the D. melanogaster-D. pseudoobscura (mel-pse) comparison, which is 
commonly used  to study cis-regulatory sequence evolution; the two populations diverged 
~25 million years ago (e.g., Ludwig et al., 2005 and references therein).  As we will 
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discuss below, blocks of sequence conservation between melanogaster spa and 
pseudoobscura are relatively few and short, and many TFBSs and novel regulatory sites 
were not alignable (Figure 2.6A).  We were therefore surprised to find that a 409-bp 
pseudoobscura sequence we identified as the putative ortholog of spa was able to drive 
cone cell-specific reporter gene expression in transgenic D. melanogaster, 
indistinguishably in pattern and intensity from melanogaster spa (Figure 2.6B). 
 We wish to point out several notable aspects of spa sequence evolution.  First, its 
distribution of sequence conservation appears to be unusual among developmental 
enhancers.  When total mel-pse sequence identity is considered, spa (65% identity) falls 
only slightly below the range of six well-studied Drosophila enhancers we analyzed for 
comparison (70% to 88%; Table S2.4).  However, spa is relatively poor in extended 
blocks of conserved sequence; it contains only one block of 100% conservation of ≥10 bp 
in length (in region 1, the RCE), constituting 3.9% of total enhancer sequence (Figure 
2.6C).  By contrast, in the six reference enhancers, an average of 52% of sequence lies in 
perfectly conserved blocks of ≥10 bp (range is 37% to 75%).  If the cutoff is lowered to 
9/10 identity, 29% of spa is in conserved blocks, while in the six reference enhancers, the 
average is 67% (range is 48% to 89%; Figure 2.6C; Table S2.4).  Even more strikingly, in 
the six reference enhancers, an average of one-third of the sequence is in perfectly 
conserved blocks of ≥20 bp (range is 20% to 58%), while spa has no conserved blocks of 
this size (Figure 2.6C; Table S2.4).  The paucity of extended blocks of conservation 
within spa is exemplified by the fact that only 24% of spa can be aligned with its 
pseudoobscura ortholog by the “BLAST 2 Sequences” algorithm  (Tatusova and 




Figure 2.6.  spa function is conserved in two Drosophila species, despite rapid turnover of 
known and novel regulatory sequences.  (A) Alignment of the spa enhancer of D. 
melanogaster (mel) and orthologous sequences from D. yakuba (yak), D. erecta (ere), D. 
ananassae (ana), and D. pseudoobscura (pse).  Known binding sites for Lz, Pnt/Yan, and 
Su(H), and predicted orthologous sites, are colored blue, green, and red, respectively.  
Regions 1 through 6 are labeled with colored bars.  TAAT motifs are underlined.  Conserved 
bases are shaded gray.  (B) The 409-bp D. pse sequence shown in panel A drives robust cone 
cell-specific gene expression in eye discs of transgenic D. mel.  (C) spa has few blocks of 
conserved sequence, based on a pairwise mel-pse enhancer alignment.  90-99% and 100% 
conserved sequence blocks are defined as contiguous ≥10 bp sequences with 90-99% or 
perfect conservation, respectively, counting gaps as mismatches.  Results for six other well-
studied developmental enhancers are shown, along with mean values.  Error bars indicate 
SEM.  (D) Conservation is a poor indicator of the regulatory significance of spa enhancer 
sequences.  “Novel regulatory” sequence is regions 1, 4, 5abc, and 6a; “non-regulatory” 
sequence is regions 2, 3, 5d, and 6b.  Sequence identity is calculated from a pairwise mel-pse 
BLASTZ alignment as ((# of identical bases)/(total bases residing in those sequences)) X 
100%. 
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42% to 99%, Table S2.5).  The genomic BLAST program at DroSpeGe (Gilbert, 2007) is 
unable to align any part of spa with D. pseudoobscura genomic sequence, whereas an 
average of 52% of the sequence of the six reference enhancers can be aligned by this 
method (range is 30% to 79%; Table S2.5).  Lack of sequence conservation does not 
appear to result from a reshuffling of regulatory sequences, as melanogaster vs. 
pseudoobscura dot-plot analysis does not detect any rearrangements within spa (Figure 
S2.6). 
 Second, of the 12 identified binding sites for Lz, Pnt/Yan, and Su(H), only three 
can be unambiguously aligned with orthologous predicted binding sites in 
pseudoobscura.  Four other predicted binding sites for these TFs were found in the 
pseudoobscura enhancer, but had no definitive orthologs in melanogaster spa, due to 
significant differences in sequence and/or position (Figure 2.6A).  The average mel-pse 
sequence identity of TFBSs in spa is 72.6%, lower than that of all six reference enhancers 
(Figures 2.6D and S3; Table S2.4).  Overall, pseudoobscura spa contains fewer predicted 
TFBSs than melanogaster spa: 1 vs. 5 predicted Su(H) sites, 2 vs. 3 predicted Lz sites, 
and 4 GGAW consensus Ets sites vs. 6 in melanogaster. 
 Third, with respect to the novel (that is, previously uncharacterized) sequences 
within spa, we do not observe a strong correlation between functional significance and 
sequence conservation.  Of those functionally essential novel sequences identified in this 
report (regions 1/4/5abc/6a), the total mel-pse sequence identity is not greatly higher than 
that of sequences making little or no contribution to activation (regions 2/3/5d/6b) (65% 
vs. 58% identity; Figure 2.6D).  Thus, in the context of the spa enhancer, we find 
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The goal of this study was to use a well-characterized, signal-regulated 
developmental enhancer to examine, in fine detail, the regulatory interactions and 
structural rules governing transcriptional activation in vivo.  Taking the elegant work of 
Flores and colleagues (2000) as a starting point, we have used functional in vivo assays to 
test the power of the proposed combinatorial code of “Notch/Su(H) + Lz + MAPK/Ets” 
to explain the activity and cell-type specificity of the spa cone cell enhancer of dPax2.  In 
the course of this work, we have discovered several surprising properties of spa that are 
not accounted for in current models of enhancer function. 
 
The spa patterning code is massively combinatorial 
 
We chose the spa enhancer for our fine-scale analysis because (1) the known 
direct regulators and their binding sites are well defined, (2) they could in theory 
constitute the sum total of the patterning information received by the enhancer, and (3) 
the enhancer, at 362 bp, is relatively small, simplifying mutational analyses.  To our 
surprise, a large proportion of the previously uncharacterized sequence within spa is vital 
for normal enhancer activity in vivo, and of that subset, a large proportion directly 








Figure 2.7.  Short-range positive and negative interactions shape the cell-type specificity 
of enhancer function.  (A) Summary of spa regulation: two functional classes of 
regulatory sites govern the enhancer activity of spa in vivo.  The spa enhancer requires 
the presence and proper arrangement of many regulatory sub-elements for its 
transcriptional activity and cell-type specificity.  Region 1 appears to be required for 
remote enhancer activity, but dispensable for patterning.  In addition, proper cell-type 
patterning of spa in the developing eye is considerably more complex than previously 
thought, and depends on short-range interactions among many regulatory sites.  Green 
arrows indicate activation mediated by sites within spa; red bars indicate cell-type-
specific repression activities.  (B) A simple “combinatorial code” model is insufficient to 
explain the cell type specificity of spa, as the same regulatory elements (represented here 
as factors a, b, c, and d) can be rearranged to generate transcription in either cone cells or 
photoreceptors.  Thus any model describing cone cell-specific transcriptional activation 
by spa must also incorporate rules of spatial organization. 
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 Activation in cone cells:  In addition to necessary inputs from Lz, Pnt, and Su(H), 
we have identified three segments of spa, regions 4, 5, and 6, that make essential 
contributions to gene expression in cone cells.  In addition, region 2 makes a relatively 
minor contribution.  (Region 1, another essential domain, will be discussed separately.)  
Fine-scale mutagenesis reveals that within regions 4/5/6, very little DNA is dispensable 
for cone cell activation.  The novel regulatory sites in spa are very likely bound by 
factors other than Lz/Pnt/Su(H), for the following reasons: no sequences resembling 
Pnt/Lz/Su(H) binding sites reside in these regions; mutations in the novel sites have 
different effects than removing the defined TFBSs or the proteins that bind them; 
doubling the known TFBSs fails to compensate for the loss of the novel sequences; and 
most importantly, mutating the novel regulatory regions does not significantly affect 
binding of the known activators to nearby binding sites in vitro (Table S2.2).  As for the 
expression pattern of the novel regulators, we cannot tell from a loss-of-function analysis 
whether they are cone cell-specific, eye-specific, or ubiquitous—we only know that 
multiple novel sites are necessary both for normal cone cell expression and ectopic PR 
expression.  Besides Lz, Pnt, and Su(H), we know of no transcriptional activators present 
in cone cells; Cut, Prospero, and Tramtrack are expressed in cone cells, but are thought to 
act as transcriptional repressors (e.g., Lai and Li, 1999; Cook et al., 2003; Sato et al., 
2006).  The transcription factor Hindsight is required for dPax2 expression and cone cell 
induction, but acts indirectly, activating Delta in R1/R6 to induce Notch signaling in cone 
cells (Pickup et al., 2009). 
 Unsurprisingly, placing the enhancer closer to the promoter boosts expression of 
spa(wt), as well as some of the impaired mutants (Figures 2.4 and S2.1).  Remember that 
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spa is located at +7 kb in its native locus, and that nearly all mutational studies place the 
enhancer immediately upstream of the promoter.  If our entire analysis had been 
performed at -121 bp, we would have underrated the functional significance of several 
critical regulatory sequences, and would have eliminated region 1 entirely as a regulatory 
site.  Other well-characterized enhancers, which have been analyzed in a promoter-
proximal position only, may therefore contain more critical regulatory sites than is 
currently realized. 
 Like many transcriptional activators, all three known direct activators of spa (or 
their orthologs) recruit p300/CBP histone acetyltransferase coactivator complexes (e.g., 
Kitabayashi et al., 1998; Barolo and Posakony, 2002).  Doubling the number of binding 
sites for these TFs (to 6 Lz, 8 Ets, and 10 Su[H] sites) does not suffice to drive cone cell 
expression in the absence of the novel regulatory regions (Figure 2.5).  It may be, then, 
that the novel activators of spa employ mechanisms that are distinct from those of the 
known activators.  The remote activity of spa, mediated by region 1, may be an example 
of such a mechanism. 
 Cell-type specificity:  We were able to convert spa into a photoreceptor R1/R6-
specific enhancer in three ways: (1) by moving the defined TFBSs to one side of the 
enhancer in a tight cluster; (2) by placing Lz and Ets sites next to regions 1/4/6a; and (3) 
by mutating regions 2/3/5/6b within spa while maintaining the native spacing of all other 
sites.  From these experiments, we conclude that spa contains short-range repressor sites 
that prevent ectopic activation in PRs by Lz + Pnt + regions 4 + 6a.  spa contains at least 
two redundant repressor sites, since both region 5 and regions 2/3/6b must be mutated to 
attain ectopic R1/R6 expression. 
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 klumpfuss, which encodes a putative transcriptional repressor, is directly activated 
by Lz in R1/R6/R7, but is also present in cone cells (Wildonger et al., 2005, and 
references therein), making it an unlikely repressor of spa.  seven-up, another known 
transcriptional repressor, is expressed in R3/R4/R1/R6 and could therefore act to repress 
spa in photoreceptors (Mlodzik et al., 1990; Cooney et al., 1993).  However, we did not 
identify putative seven-up binding sites within spa.  Phyllopod, an E3 ubiquitin ligase 
component, represses dPax2 and the cone cell fate in R1/R6/R7, but the transcription 
factor mediating this effect is not yet known (Shi and Noll, 2009).  Perhaps the best 
candidate for a photoreceptor-specific direct repressor of spa is Bar, which encodes the 
closely related and redundant homeodomain TFs BarH1 and BarH2.  Bar expression is 
activated by Lz in R1/R6 and is required for R1/R6 cell fates (Higashijima et al., 1992; 
Crew et al., 1997).  Furthermore, misexpression of BarH1 in presumptive cone cells can 
transform them into photoreceptors (Hayashi et al., 1998).  It is unclear whether Bar-
family proteins act as repressors, activators, or both.  BarH1/2 can bind sequences 
containing the homeodomain-binding core consensus TAAT (Noyes et al., 2008), and 
region 5 of spa contains two TAAT motifs (underlined in Figure 2.6A).  Future studies 
will explore the possibility that Bar directly represses spa in photoreceptors. 
 The combinatorial code of spa, then, requires multiple inputs in addition to Lz, 
MAPK/Ets, and Notch/Su(H).  Indeed, our data suggest that the known regulators can 
contribute to expression in multiple cell types, depending on context.  The novel control 
elements we have identified within spa are necessary not only to facilitate transcriptional 




Functional evidence for a new enhancer regulatory element, mediating remote 
interactions but not patterning 
 
Enhancers are often located many kilobases from the promoters they regulate. 
Enhancer-promoter interactions over such distances are very likely to require active 
facilitation (Rippe, 2001).  Even so, few studies have focused specifically on 
transcriptional activation at a distance, and the majority of this work involves locus 
control regions (LCRs) and/or complex multigenic loci, which are not part of the 
regulatory environment of most genes and enhancers (e.g., Yoshida et al., 1999; Carter et 
al., 2002; Song et al., 2007).  Like spa, many developmental enhancers act at a distance 
in their normal genomic context, yet can autonomously drive a heterologous promoter in 
the proper expression pattern, without requiring an LCR or other large-scale genomic 
regulatory apparatus.  However, in nearly all assays of enhancer function, the element to 
be studied is placed immediately upstream of the promoter.  In such cases, regulatory 
sites specifically mediating remote interactions cannot be identified.  Because our initial 
mutational analysis of spa was performed on enhancers placed at a moderate distance 
from the promoter (-846 bp), we were able to screen for sequences required only at a 
distance, by moving crippled enhancers to a promoter-proximal position.  Only one 
segment of spa, region 1, was absolutely essential at a distance but completely 
dispensable near the promoter.  This region, which contains the only block of extended 
sequence conservation within spa, plays no apparent role in patterning, or in basic 
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activation at close range.  We therefore call this segment of spa a “remote control” 
element (RCE). 
 The remote enhancer regulatory activity described here differs from previously 
reported long-range regulatory mechanisms in two important ways.  First, the remote 
function of spa does not require any sequences in or near the dPax2 promoter.  This 
functionally distinguishes spa from enhancers in the Drosophila Hox complexes that 
require promoter-proximal “tethering elements” and/or function by overcoming insulators 
(e.g., Calhoun et al., 2002; Chen et al., 2005, Akbari et al., 2008).  This distal activation 
mechanism also likely differs from enhancer-promoter interactions mediated by proteins 
that bind at both the enhancer and the promoter, as occurs in looping mediated by ER, 
AR, and Sp1 (Wang et al., 2005; Williams et al., 2007; Pan et al., 2008).  Second, studies 
of distant enhancers of the cut and Ultrabithorax genes have revealed a role for the 
cohesin-associated factor Nipped-B, especially with respect to bypassing insulators 
(Misulovin et al., 2008, and references therein), but it has not been demonstrated that 
Nipped-B, or any other enhancer-binding regulator, is required only when the enhancer is 
remote. 
 To our knowledge, the spa RCE is the first enhancer sub-element demonstrated to 
be essential for enhancer-promoter interactions at a distance, but unnecessary for 
proximal enhancer function and cell-type specificity.  However, the present work 
contains only a limited examination of this activity, as part of a broader study of enhancer 
function.  We are currently extending these functional studies, testing for potential 
promoter preferences and distance limitations, and pursuing the identities of factors 




Enhancer structure: shaped and constrained by short-range patterning interactions 
 
As discussed above, it is fairly easy to switch spa from cone cell expression to 
R1/R6 expression (though, curiously, we have yet to generate a construct that is active in 
both cell types).  Our results show that multiple regions of spa mediate a repression 
activity in R1/R6 but not in cone cells.  We further conclude that these spa-binding 
repressor(s) act in a short-range manner; that is, they must be located very near to 
relevant activator binding sites, since moving Lz and Pnt sites to one side of spa, without 
removing the repressor sites (KO+synthCS), abolishes repression.  Despite this failure of 
repression, synergistic interactions among Lz + Ets sites and novel sequences still occur 
in this re-organized enhancer—at least in R1/R6 cells.  Cone cell-specific expression is 
lost, however, revealing (along with other experiments) that transcriptional activation in 
cone cells is highly sensitive to the organization of regulatory sites within spa.  Slightly 
wider spacing of regulatory sites (KO+synthNS) kills the enhancer altogether, suggesting 
that synergistic positive interactions within spa, though apparently longer in range than 
repressive interactions, are severely limited in their range.  The structural organization of 
spa, then, appears to be constrained by a complex network of short-range positive and 
negative interactions (Figure 2.7B).  Activator sites must be spaced closely enough to 
trigger synergistic activation in cone cells; at the same time, repressor sites must be 
positioned to disrupt this synergy in non-cone cells, preventing ectopic activation. 
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 Recent work by Crocker et al. (2008) has shown that changes to enhancer 
organization can “fine-tune” the output of a combinatorial code, subtly changing the 
sensitivity of the enhancer to a morphogen.  Given the importance of the structure of the 
spa enhancer for its proper function, we propose that any combinatorial code model, no 
matter how complex, is insufficient to describe the regulation of spa, since the same 
components can be rearranged to produce drastically different patterns. 
 
Conservation of spa function despite lack of sequence conservation: insights into 
enhancer structure 
 
One might expect that the regulatory and organizational complexity of the spa 
enhancer, and its extreme sensitivity to mutation, would be reflected in strict evolutionary 
constraints upon enhancer sequence and structure.  Yet we observe very poor 
conservation of spa sequence, both in the known TFBSs and in novel regulatory elements 
shown to be critical for the function of melanogaster spa.  The reduced presence of 
Lz/Ets/Su(H) sites in D. pse could potentially be attributed to redundancy of those sites in 
D. mel, or to compensatory gain of binding sites for alternate factors in the D. pse 
enhancer.  Perhaps more difficult to understand is the apparent loss of critical regulatory 
sequences in regions 4, 5, and 6a in D. pse; our experiments in D. mel suggest that the 
absence of those inputs would result in loss of cone cell expression and/or ectopic 
activation.  It remains possible that many of these inputs are in fact conserved, but that 
conservation is not obvious due to binding site degeneracy and/or rearrangement of 
elements within the enhancer.  Fine-scale comparative studies are ongoing. 
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 spa is by no means the first example of an enhancer that is functionally 
maintained despite a lack of sequence conservation (for a review of this topic, see 
Wittkopp, 2006).  The most thoroughly characterized example of this phenomenon is the 
eve stripe 2 enhancer; its function is conserved despite changes in binding site 
composition and organization (Ludwig et al., 2000; Ludwig et al., 2005; Hare et al., 
2008).  Note, however, that the sequence of spa has changed much more rapidly than that 
of eve stripe 2 (Figures 2.6 and S2.4-S2.5), with no apparent change in function.  In 
general, the ability of an enhancer to maintain its function in the face of rapid sequence 
evolution suggests that enhancer structure must be quite flexible.  These observations 
support the “billboard” model of enhancer structure, which proposes that as long as 
individual regulatory units within an enhancer remain intact, the organization of those 
units within the enhancer is flexible (Arnosti and Kulkarni, 2005). Yet our findings 
concerning the importance of local interactions among densely clustered, precisely 
positioned transcription factors are more consistent with the tightly structured 
“enhanceosome” model (Thanos and Maniatis, 1995).  Further structure-function analysis 











Generation of mutant and synthetic enhancers 
 
 The 362-bp sparkling enhancer was amplified from w1118 genomic DNA with the 
following primers: 5’-CACCGGATCCgtatcaagtaactgggtgcctaattg-3’; 5’-
GGGTCTAGAcctaagctaccggaaaacaacttg-3’.  The 409-bp D. pseudoobscura spa 
enhancer was PCR-amplified from genomic DNA with the following primers: 5’-
CACCGGATCCgtctcaaataacttcgtgtc-3’; 5’-GGGTCTAGAcacaggaagccggaaactg-3’.  
Lower-case sequence is homologous to genomic DNA. 
 Most mutant spa constructs were generated by one of three PCR techniques: (1) 
amplification of spa(wt) with tagged primers to create mutations at the 5’ or 3’ end; (2) 
overlap extension (sewing) PCR to generate internal mutations; or (3) assembly PCR to 
synthesize enhancers with multiple mutations.   
 In mutating novel enhancer sequences, we made non-complementary 
transversions to every other base pair.  We left 2-4 bp of non-mutated sequence to either 
side of every TFBS (as defined by consensus sequences), to avoid interfering with TF 
binding.  In mutating TFBSs, we converted Lz sites from RACCRCA to RAAARCA; Ets 
sites from GGAW to TT
 
AW; and Su(H) sites from YGTGDGAA (or related sequence) 
to YGTGDCAA; these changes eliminate TF binding in vitro (Barolo et al., 2000; Flores 
et al., 2000; references therein). 
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Enhancer cloning, vectors, and transgenesis 
 
PCR-amplified enhancer constructs were TOPO-cloned into the pENTR/D-TOPO 
vector (Invitrogen).  Spa(synthCS) was created by annealing two complementary 
oligonucleotides and ligation into the Gateway donor vector pBS-ENTR-TOPO 
(Swanson et al., 2008).  Subcloned constructs were then Gateway-cloned into the 
Ganesh-G1 GFP reporter vector (Swanson et al., 2008) via LR recombination 
(Invitrogen), with the following exception: constructs placed at -121 bp from the 
promoter (Figure 2.4) were Gateway-cloned into Ganesh-G2, which lacks the 0.7-kb 
spacer sequence between the recombination cloning site and the promoter (Swanson et 
al., 2008).  P element transformation was performed essentially as described by Rubin 
and Spradling (1982).  W1118 flies were used for transgenesis. 
 
Tissue preparation, staining, and microscopy 
 
Eye tissues were dissected from transgenic third-instar larvae or 24-hour pupae 
and fixed in 4% formaldehyde in PBS for 30 minutes at room temperature.  For larval 
imaginal discs, GFP fluorescence was imaged with an Olympus BX51 microscope and an 
Olympus DP70 digital camera.  Pupal eyes were stained with antibodies to GFP (see 
below) and imaged with an Olympus IX71 inverted microscope and an Olympus FV500 
confocal system.  Primary antibodies used: rabbit anti-EGFP (a gift from B. Novitch), 
diluted 1:100; mouse anti-Cut 2B10 (a gift from K. Cadigan), diluted 1:100; mouse anti-
Elav 9F8A9 (Developmental Studies Hybridoma Bank), diluted 1:100. 
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DNA sequence alignment 
 
The sparkling multi-species alignment is based on BLASTZ alignments and was 
taken from the UCSC genome browser (http://genome.ucsc.edu).  Pairwise mel-pse 
alignments were performed using zPicture (Ovcharenko et al., 2004; 
http://zpicture.dcode.org).  Pairwise BLAST searches were performed with the “BLAST 
2 Sequences” algorithm at NCBI (Tatusova and Madden, 1999; 
www.ncbi.nlm.nih.gov/BLAST/bl2seq/wblast2.cgi) and at DroSpeGe (Gilbert, 2007; 
http://insects.eugenes.org/species). 
 
Protein expression and purification 
 
Lozenge protein was expressed using the TNT T7 Coupled Reticulocyte Lysate 
System (Promega) from pET3c-Lz (kindly provided by Richard Mann, Columbia 
University).  His-tagged Su(H) was expressed from pRSET-6XHis-Su(H) (kindly 
provided by Jim Posakony, University of California, San Diego).  RosettaBlue (DE3) 
Competent Cells (Novagen) transformed with pRSET-6XHis-Su(H) were grown 
overnight in 250 ml of LB plus 30 µg/ml carbenicillin in a 37°C shaking incubator.  The 
next morning, cells were spun down for 10 min at 6000 rpm, and the pellet was 
resuspended in 10 ml LB.  Two 500 ml LB+carb cultures were each inoculated with 2.5 
ml of resuspended cells and grown in a 30°C shaking incubator until they reached an 
OD600 of 0.6-0.7.  Each 500 ml culture was then induced with 500 µl 1M IPTG and 
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grown at 30°C for an additional 2 hours.  Cultures were spun down at 4°C for 10 min at 
6000 rpm.  Each pellet was resuspended on ice in 10 ml of lysis buffer (0.1 M NaCl, 
0.1% Tween-20, 10 mM Tris-Cl (pH 8.0), 5 mM Imidazole, 1 mM DTT, 1 mM PMSF, 1 
tablet Complete Mini EDTA-free (Roche)).  Cells were lysed at 4°C by sonication (60% 
power, 5 X 30s, at 30s intervals), then centrifuged for 20 min at 10000 rpm at 4°C.  All 
following purification steps took place in a 4°C cold room.  Two 0.8 X 4 cm Poly-Prep 
Chromatography Columns (Bio-Rad) were packed with 0.15 ml of Ni-NTA agarose 
(Qiagen) and cleared with 10 ml Wash Buffer 1 (0.1 M NaCl, 0.1% Tween-20, 10 mM 
Tris-Cl (pH 8.0), 5 mM Imidazole).  Ten ml of supernatant was then applied to each 
column.  Each column was washed with 1 ml Wash Buffer 1, followed by 1 ml Wash 
Buffer 2 (0.1 M NaCl, 10 mM Tris-Cl (pH 8.0), 15 mM Imidazole).  Protein was eluted 
with 6 X 100 µl elution buffer (0.1 M NaCl, 10 mM Tris-Cl (pH 8.0), 200 mM 
Imidazole, pH adjusted to 8.0).  Elutions containing protein were pooled and glycerol was 
added to 10% final concentration before being aliquoted, flash frozen with dry ice and 
ethanol, and stored at -80°C. 
 
In vitro binding assays 
 
Gel shift probes were made using custom oligos from either Invitrogen or IDT.  
Gel shift probe labeling reactions contained 37 µl dH2O, 5 µl 10X PNK Buffer, 1 µl top 
strand oligo (2 µM), 1 µl bottom strand oligo (2 µM), 5 µl γ32P, and 1 µl T4 PNK (NEB).  
Reactions were incubated at 37°C for one hour, boiled at 80°C for 5 min, then allowed to 
cool slowly to room temperature.  Labeled probes were purified twice using Illustra 
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ProbeQuant G-50 Micro Columns (GE).  The Lz probe contained the first Lz site from 
spa along with flanking sequence.  The Su(H) probe contained the third Su(H) site from 
spa along with flanking sequence.  The sequences of labeled probes are below, with Lz 
sites in blue, Su(H) sites in red, and binding site mutations in bold and underlined: 
Lz: 5’-aaaatttactatGACCGCAaagctgtttcc-3’ 
MutLz:  5’-aaaatttactatGAAA
Su(H):  5’-tcaagatcttaTTCACATTgaaattgaagc-3’ 
GCAaagctgtttcc-3’ 
MutSu(H):  5’-tcaagatcttaTTGGG
Cold competitors were assembled as follows: 10X - 25 µl dH2O, 5 µl 10X PNK Buffer, 
10 µl top strand oligo (2 µM), 10 µl bottom strand oligo (2 µM); 100X - 43 µl dH2O, 5 µl 
10X PNK Buffer, 1 µl top strand oligo (200 µM), 1 µl bottom strand oligo (200 µM); 
1000X - 25 µl dH2O, 5 µl 10X PNK Buffer, 10 µl top strand oligo (200 µM), 10 µl 
bottom strand oligo (200 µM).  Cold competitors were incubated at 37°C for one hour, 
boiled at 80°C for 5 min, then allowed to cool slowly to room temperature.  Sequences of 
cold competitor probes match the sequences of in vivo reporter constructs, and include 
region of interest along with adjacent binding sites and additional flanking sequence on 
either side.  Sequences of cold competitors are below, with Lz sites in blue, Su(H) sites in 
red, Ets sites in green, binding site mutations in bold and underlined, and mutations 
outside binding sites in alternating caps and lower case, where the bases in caps have 
























































Gel shifts reactions were assembled on ice and contained 1 µl 10X Gel Shift Buffer (0.1 
M Tris-HCl pH 7.5, 0.5 M NaCl, 10 mM DTT, 10 mM EDTA, 275 µg/ml salmon sperm 
DNA), 1 µl poly d(I-C) (1 mg/ml), 1 µl DTT (100 µM), 1 µl labeled probe, 1 µl 
competitor (if included), and protein and dH2O to a final volume of 10 µl.  Lozenge gel 
shift reactions contained 3 µl of TNT reaction, while Su(H) gel shift reactions contained 
5 µl of purified 6XHis-Su(H).  Gel shift reactions were incubated on ice for 15 min 
before being loaded into 5% or 6% acrylamide gels that had been pre-run for 30 min; gels 
were then run at 120-140V in 0.5X TBE.  Gels were dried for one hour at 80°C, exposed 
overnight to a storage phosphor screen (GE), and scanned using a Typhoon 9400 
Variable Mode Imager.  Quantification was performed using ImageJ.  Calculations of 






This manuscript was written by Christina I. Swanson, Nicole C. Evans, and Scott 
Barolo.  This research was supported in part by a Center for Organogenesis Training 
Grant (5T32HD007505) to C.I.S. and by NIH grant GM076509 to S.B.  We thank Ying 
Zhao, Zeeshaan Bhatti, and Trish Hinrichs for research support, and Ben Novitch and 
Ken Cadigan for sharing reagents.  We are grateful to the following people for helpful 
discussions: Ken Cadigan, Tim Blauwkamp, Deneen Wellik, Ben Novitch, Doug Engel, 
 56 
Tom Glaser, Trisha Wittkopp, Jim Posakony, Billy Tsai, Albert Erives, Robert Drewell, 





Supplemental Table S2.1.  Summary of transgenic reporter expression data.  All 
constructs are placed at -846 bp from promoter, except those labeled “-121,” which are 
placed at -121 bp.  CC, cone cell expression; PR, photoreceptor 1+6 expression.  3 to 14 
independently derived transgenic lines were examined for each construct.  See Figure 2.2 
for scoring key.  Asterisks on lines of spa(synthCS) and 2xspa(synthCS) denote lines with 
weak and incomplete R1+R6 expression, plus weak-to-moderate expression at the 
posterior margin of the eye disc, which, based on z-position and nuclear size, is likely to 





































Supplemental Table S2.2.  Novel regulatory regions of spa do not significantly 
contribute to in vitro binding of the known regulatory TFs.  Experimental details and 
probe sequences are described in Experimental Procedures.  Probes include novel 
regulatory regions 1, 4, 5, or 6a, plus any immediately flanking Lz, Su(H), or Ets binding 
sites (see Figure 2.6A for annotated sequence).  Left, Lz binding to sites flanking regions 
1, 5, and 6a; right, Su(H) binding to sites flanking regions 4 and 6a.  Pnt binding was not 
examined, because the predicted Ets sites flanking these enhancer regions do not bind Pnt 
in vitro (Flores et al, 2000).  In all cases, mutations to novel regulatory regions of spa (all 
of which reduce enhancer activity in vivo) do not significantly affect binding of Lz or 
Su(H) to nearby sites.  By contrast, binding is reduced in all cases by mutating the Lz or 
Su(H) sites themselves (red figures).  Note that mutating Su(H) sites has a milder effect 
on binding than mutating Lz sites, and that a greater excess of competitor is required for 
Su(H) than for Lz.  This apparent difference in relative binding strength is consistent with 
the fact that the Lz sites perfectly match the optimal binding consensus, while the Su(H) 
sites deviate from the optimal consensus and are predicted to be lower-affinity sites 















Supplemental Figure S2.3.  A synthetic version of spa, containing only Su(H)+Lz+Ets 
binding sites, is poised for activation in multiple cell types of the developing eye.  
spa(synthNS), a synthetic enhancer containing the Su(H)+Lz+Ets sites from spa in their 
native arrangement, placed at -846 bp upstream of a promoter, is inactive in all cell types 
of the eye, in all 8 lines examine (A).  When this construct was placed closer to the 
promoter (-121 bp), no expression was observed in 5 of 7 independent transgenic lines 
(B).  However, 2 of 7 lines show insertion site-dependent activity in the eye: one line is 
active in cone cells, as shown by co-expression with Cut (C), while another line is active 














Supplemental Table S2.4.  D. melanogaster-D. pseudoobscura sequence identity and 
blocks of conservation within spa and six other developmental enhancers.  (a) Derived 
from BLASTZ alignments of orthologous enhancer sequences.  Calculated as ((# 
matched bases in a BLASTZ alignment)/(mel sequence length)) X 100%.  (b) TFBSs, 
transcription factor binding sites.  Binding site definitions taken from previous reports, 
references below.  (c) mel-pse sequence identity of all defined or predicted transcription 
factor binding sites (TFBSs) in seven enhancers.  Orthologous sequences are taken from 
BLASTZ alignments. (d) Derived from BLASTZ alignments of orthologous enhancer 
sequences.  Defined as the total length of contiguous sequences of ≥10 bp in which ≥90% 
of bp are conserved (counting gaps as mismatched bases), as a percentage of total 
enhancer length.  (e) Defined as the total length of contiguous conserved sequences of 
≥10 bp or  ≥20bp (counting gaps as mismatched bases), as a percentage of total enhancer 
length.  (f) Nellesen et al, 1999; (g) Barolo et al, 2000; (h) Sun et al, 1995; Yang et al, 
2000; Zaffran et al, 2001; Stultz et al, 2006; (i) Halfon et al, 2000; (j) Small et al, 1992; 



















Supplemental Figure S2.5.  Alignability of D. melanogaster and D. pseudoobscura 
orthologs of spa and six other developmental enhancers.  (a) mel enhancer sequence 
alignable with orthologous pse sequence by the BLAST 2 Sequences program at NCBI 
(www.ncbi.nlm.nih.gov/BLAST/bl2seq/wblast2.cgi; Tatusova and Madden, 1999).  
Default settings were used, with the following exceptions: the “open gap” penalty was set 
to 2, the “extension gap” penalty was set to 1, and the low-complexity filter was disabled.  
(b) mel enhancer sequence alignable with total pse genomic sequence by the BLAST 
program at DroSpeGe (insects.eugenes.org/species/blast; Gilbert, 2007).  Default settings 


















Supplemental Table S2.6.  Dot-plot alignment of D. melanogaster spa with orthologous 
sequences from D. pseudoobscura.  The plot was created in zPicture (Ovcharenko et al, 
2004; http://zpicture.dcode.org) from a BLASTZ alignment.  Co-linear sequence 
conservation indicates that no large-scale rearrangements of enhancer structure have 










CONSERVATION OF ENHANCER FUNCTION DESPITE EVOLUTION OF 




 Enhancers are cis-regulatory elements (CREs) that control the level, timing, and 
cell-type specificity of gene expression.  Enhancers are composed of transcription factor 
binding sites (TFBSs) which recruit sequence-specific transcription factors and cofactors 
in order to regulate the transcriptional state of the target gene (Orphanides and Reinberg, 
2002).  In some enhancers, the organization of TFBSs is also critical for enhancer 
function (Thanos and Maniatis, 1995; Erives and Levine, 2004; Senger et al, 2004).  
Therefore, both the DNA sequence and the structure are important for enhancer function.  
However, evolutionary analyses of CREs reveal rapid evolution of enhancer sequences 
that could alter both TFBS sequence and overall enhancer structure, potentially affecting 
enhancer function (Richards et al, 2005; Moses et al, 2006; Li et al, 2007). 
 Several studies have shown that evolution of enhancer sequences can lead to 
changes in gene expression; in some cases, enhancer evolution is responsible for 
morphological differences between two species (Shapiro et al, 2004; Gompel et al, 2005; 
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Marcellini and Simpson, 2006, Jeong et al, 2008; Williams et al, 2008).  However, it 
seems likely that selective pressure acts to preserve the function of most CREs.  Indeed, 
there are many examples of enhancers that have retained their function despite sequence 
divergence (Takahashi et al, 1999; Fisher et al, 2006; Piano et al, 1999; Yamamoto et al, 
2007; Wratten et al, 2006).  In some of these examples, the sequence is so degenerate that 
typical alignment tools are unable to align functionally conserved elements (Fisher et al, 
2006; Wratten et al, 2006).  In most cases, the direct regulatory inputs governing 
enhancer activity are conserved, yet the number and organization of transcription factor 
binding sites (TFBS) has changed, suggesting rapid binding site turnover has occurred 
(Piano et al, 1999; Wratten et al, 2006).  It has been suggested that enhancer activity is 
maintained despite mutation of important regulatory sequences due to binding site 
redundancy, compensatory mutations, and organizational flexibility (Ludwig, 2002; 
Wittkopp, 2007).  However, these hypotheses have rarely been tested experimentally. 
The best in vivo evidence for the structure-function implications of enhancer 
evolution comes from analyses of the Drosophila even-skipped stripe 2 enhancer (eve 
S2E).  This enhancer drives expression of eve in a transverse stripe of cells in the 
syncytial Drosophila embryo (Goto et al, 1989; Harding et al, 1989).  The function of eve 
S2E is conserved not only among Drosophilids, but also among a more distantly related 
group of flies, the sepsids (Ludwig et al, 1998; Hare et al, 2008).  However, S2E 
sequence comparisons reveal significant divergence, including poor conservation of 
binding sites and changes in spacing between TFBS (Ludwig and Kreitman, 1995; 
Ludwig et al, 1998; Hare et al, 2008).  It was proposed that the eve S2E is evolving under 
stabilizing selection, and that compensatory mutations have occurred in each lineage to 
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preserve enhancer function despite turnover of functionally important binding sites.  This 
hypothesis was directly tested for the Drosophila melanogaster (D. mel) and Drosophila 
pseudoobscura (D. pse) stripe 2 enhancers.  Chimeric enhancers containing sequences 
from both the D. mel and D. pse stripe 2 enhancers cannot recapitulate the endogenous 
stripe 2 expression pattern, presumably because compensatory mutations in both lineages 
have rendered D. mel and D. pse enhancer sequences incompatible (Ludwig et al, 2000).  
However, beyond this elegant work with the eve S2E, very little has been done to 
examine the nature of enhancer evolution in vivo.   
Evolutionary comparisons have the potential to provide valuable insight into the 
rules that govern structure and function of enhancer elements.  Therefore, we decided to 
analyze the evolution of the Drosophila D-Pax2 sparkling enhancer (spa).  Spa is an 
excellent candidate for evolutionary analysis for several reasons: the regulation of spa has 
been well characterized; all the regulatory sequences within a minimal version of spa 
have been finely mapped; unlike eve S2E, it is signal-regulated enhancer; previous 
studies have identified strict constraints on enhancer structure; and sequence alignments 
reveal rapid evolution of enhancer sequences (Flores et al, 2000; Swanson et al, 2010).   
The D. mel spa enhancer drives cone cell-specific expression of D-Pax2 during 
Drosophila eye morphogenesis; expression of D-Pax2 in the cone cells is essential for 
their proper fate specification (Fu and Noll, 1997; Fu et al, 1998).  The spa enhancer 
contains twelve mapped TFBS which mediate three direct regulatory inputs: Notch 
signaling via binding of Suppressor of Hairless (Su(H)); EGFR/MAPK signaling via 
binding of the Ets proteins Pointed P2 (PntP2, an activator) and Yan (a repressor); and 












Figure 3.1.  Functional conservation of the D. melanogaster and D. pseudoobscura 
sparkling enhancers.  (A)  The regulation of D. mel spa is complex; in addition to twelve 
characterized binding sites for Lozenge (blue), the Ets proteins PointedP2 and Yan 
(yellow), and Suppressor of Hairless (red), spa contains essential regulatory elements in 
the regions labeled 1, 4, 5, and 6A (Flores et al, 2000; Swanson et al, 2010).  The 
regulatory sequences in Regions 4 and 6A contribute to transcriptional activation in 
multiple cell types, whereas regulatory sequences in Region 5 contribute to cone cell-
specific activation.  Region 5 also contains a position-dependent element that represses 
gene expression in the photoreceptors.  Region 1 is not required for proper transcriptional 
activation or patterning when the enhancer is proximal to the promoter, but is required 
when the enhancer is located at a distance from the promoter, suggesting that Region 1 
mediates long-distance enhancer-promoter interactions (blue arrow).  The organization of 
these regulatory elements within D. mel spa is also critical for proper transcriptional 
activation and gene patterning.  (B)  The D. mel spa enhancer, placed 846 bp upstream of 
a GFP reporter, drives cone cell-specific gene expression in late third instar larval 
imaginal eye discs.  (C)  The D. pse spa enhancer drives cone cell-specific gene 
expression at levels indistinguishable from the D. mel spa enhancer. 
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the mapped binding sites for Su(H), PntP2/Yan, and Lz, there are critical regulatory 
elements in several other regions of the enhancer, although the proteins that may bind 
those elements have not yet been identified (Figure 3.1A, Swanson et al, 2010).  
Alignments reveal an overall lack of sequence conservation within spa, and more 
specifically poor conservation of critical regulatory elements.  Nevertheless, the 
orthologous D. pse spa enhancer is capable of driving reporter gene expression in a 
pattern that is indistinguishable from that driven by the D. mel spa enhancer (Figure 
3.1B-C, Swanson et al, 2010).  We have characterized the differences in regulation and 
organization of the D. mel and D. pse spa enhancers in order to understand how two 
enhancers with such different sequences and structures can generate identical 
transcriptional outputs.  By building chimeric enhancers containing sequences from both 
mel spa and pse spa, we discovered that the organization of regulatory elements within 
these two enhancers is surprisingly divergent.  In addition, while both enhancers respond 
to the same direct regulatory inputs, binding site turnover events have led to changes in 
TFBS composition.  Our findings provide insight into the mechanisms by which spa 
function was maintained despite mutation of important regulatory sequences and 











Conservation of function, but not sequence, in the spa enhancer 
  
 Previous studies have revealed complexity in both the regulation and organization 
of the D. mel spa enhancer.  As stated above, spa is directly bound by the transcription 
factors Lz, PntP2/Yan, and  Su(H); each of these inputs is required for enhancer function 
(Figure 3.1A, Flores et al, 2000).  The sequences outside these characterized binding sites 
were subdivided into smaller regions (1A-1C, 2, 3, 4A-C, 5A-D, 6A-B) that were 
individually tested for regulatory function (Figure 3.1A, Figure 3.2; Swanson et al, 2010).  
Regions 1A through 1C, 4A through 4C, 5A through 5C, and 6A were all found to make 
essential contributions to enhancer function; for the duration of this report these 
sequences will be referred to as Regions 1, 4, 5, and 6A.  The regulatory functions of 
these novel regions are distinct from one another; Region 1 is required only when the 
enhancer is located at a distance from the promoter, Regions 4 and 6A can contribute to 
transcriptional activation in multiple cell types, and Region 5 is necessary for both 
activation in cone cells and repression in photoreceptors (Figure 3.1A).  Thus D. mel spa 
is combinatorially regulated by Lz, Pnt, Yan, Su(H), and an unknown number of 
additional regulatory factors binding within Regions 1, 4, 5, and 6A. 
 The organization of these regulatory elements within D. mel spa is also a critical 
component of enhancer function.  Changes in spacing between TFBS can alter the 










Figure 3.2.  Alignment of D. mel and D. pse spa enhancer sequences.  The alignment 
was generated by ClustalW using the default settings (Chenna et al, 2003); see 
supplemental figures for additional alignments.  Lz binding sites are blue, Ets binding 
sites are orange (rather than yellow as in other figures, so that text is readable), and Su(H) 
sites are green.  Binding sites in D. mel spa have been confirmed experimentally (Flores 
et al, 2000); binding sites in D. pse spa are predicted and have not yet been tested for in 
vitro binding.  Colored boxes above sequence designate D. mel regions as defined in our 
previous analysis of spa.  Stars marked conserved bases.  This alignment was used to 
design regional swap experiments described in Figure 3.3. 
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other times resulting in increased transcriptional activation (Swanson et al, 2010).  
Rearrangement of regulatory elements within spa can also impair enhancer function; in 
some cases, rearrangements can switch the cell-type specificity of the enhancer, 
activating transcription in photoreceptors but not in cone cells (Swanson et al, 2010).  
Therefore, spatial relationships among regulatory elements in D. mel spa are crucial for 
proper transcriptional activation and patterning of gene expression.  Because of the 
complex nature of spa structure and function, we expected the evolution of spa sequence 
to be highly constrained.  Surprisingly, that is not the case; spa sequences appear to be 
evolving rapidly based on an overall lack of sequence conservation (Figures 3.2, S3.1, 
S3.2). 
 We tested the functional conservation of the D. mel and D. pse spa enhancers by 
comparing their ability to drive reporter gene expression in transgenic Drosophila 
imaginal eye discs.  For all reporter gene constructs, we examined reporter gene 
expression in at least five independent transgenic lines.  Although the sequences of the D. 
mel and D. pse spa enhancers are divergent, they drive reporter gene expression in 
patterns that are indistinguishable from one another, both in level and cell-type specificity 
(Figure 3.1B-C).  We concluded that the spa enhancer is functionally conserved between 
D. mel and D. pse. 
Sequence alignments reveal that many of the regulatory elements critical to 
proper function of D. mel spa are poorly conserved (Figures 3.2, S3.2, S3.2).  Only two 
regulatory elements from D. mel spa are clearly conserved among all twelve sequenced 
Drosophila species:  the Lz1 site and the Region 1 regulatory element (Figure 3.2, Figure 
S3.1).  D. mel and D. pse spa also share the Ets1 site (Figure 3.2).  Beyond those three 
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regulatory elements, it is difficult to say with confidence whether any of the remaining 
regulatory elements in D. mel spa have direct orthologs in D. pse spa; it is possible that 
the single Su(H) site, the second Lz site, and one or two of the Ets sites in D. pse are 
orthologous to sites in D. mel spa, but it seems equally likely that these sites are not 
orthologous to D. mel sites based on sequence and position within the D. pse enhancer.  
Overall, there are only seven putative sites for Lz, Ets, and Su(H) proteins in D. pse, as 
opposed to twelve binding sites for those proteins in D. mel  (Figure 3.2).  Further 
experimentation is necessary to characterize putative binding sites in D. pse spa, both in 
vitro and in vivo.  Finally, although the specific, essential regulatory sequences within 
Regions 4, 5, and 6A have not been identified, we do not detect sequence conservation in 
those regions.  In conclusion, sequence comparisons reveal a lack of conservation of 
essential regulatory elements and a significant change in TFBS composition in the spa 
enhancer despite a conservation of overall enhancer function. 
 
The sparkling enhancer is evolving under stabilizing selection 
 
 The composition of binding sites within spa has been rapidly evolving; although 
the conservation of unmapped TFBS from 4, 5, and 6 is unclear, most binding sites for 
Lz, PntP2/Yan, and Su(H) are not strictly conserved.  Such rapid turnover of binding site 
composition suggests that compensatory mutations may have occurred within D. pse spa 
to preserve its function.  To test this hypothesis, we built chimeric constructs combining 
sequences from both the D. mel spa and D. pse spa enhancers and tested whether regions 













Figure 3.3.  D. mel spa and D. pse spa sequences are not functionally equivalent.  (A-B) 
Chimeric constructs combining sequences from D. mel and D. pse spa are unable to 
exactly recapitulate the wild-type expression of either endogenous enhancer; gray 
sequences are from D. mel and green sequences are from D. pse.  The mel5’+pse3’ 
chimera is unable to activate transcription (A), while the pse5’+mel3’ chimera activates 
cone cell-specific expression, but at elevated levels compared to either wild-type 
enhancer (compare to Figure 3.1 B-C).  Furthermore, D. mel Region 4, 5, and 6A 
sequences cannot be replaced by orthologous sequences from D. pse spa (C-E).  The 
function of Region 1 is conserved, as orthologous sequence from D. pse spa can 
functionally replace D. mel spa Region 1 (F). 
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 First, we tested the ability of the 5’ half of D. mel spa and the 3’ half of D. pse 
spa to cooperatively activate gene expression.  Surprisingly, this chimeric construct was 
unable to drive reporter gene expression in vivo (Figure 3.3A), indicating essential 
regulatory sites are absent from this construct.  In contrast, the reciprocal chimera, 5’ D. 
pse spa plus 3’ D. mel spa, drives robust cone-cell specific gene expression, but at levels 
that exceed the expression of either intact endogenous enhancer (Figure 3.3B).  The 
ability of this construct, pse5’+mel3’ chimera, to drive gene expression at elevated levels 
suggests an increased number of activator sites in this chimeric enhancer compared to 
either wild-type enhancer; interestingly, this chimera only contains 9 Lz/Ets/Su(H) sites, 
fewer than D. mel spa, indicating that extra activation may come from unmapped binding 
sites.  Neither chimeric enhancer can recapitulate wild-type spa function; one enhancer is 
transcriptionally inactive, while the other activates cone cell-specific expression, but not 
at wild-type levels.  The lack of compatibility between the mel and pse 5’ and 3’ halves 
suggests that the differences in TFBS composition and organization between these two 
enhancers are functionally relevant..   
 The lack of activity from mel5’+ pse3’ indicates that the 3’ end of D. pse spa lacks 
critical regulatory elements that are located at the 3’ end of D. mel spa.  D. mel spa 
contains essential regulatory sequences in Regions 4, 5, and 6A that do not appear to be 
conserved based on sequence alignments.  However, it seemed possible that some or all 
of these regions are functionally conserved, but that conservation is not apparent, perhaps 
because of degeneracy in binding site sequence.  We tested the functional conservation of 
these regions by replacing sequence in D. mel spa with orthologous sequence from D. pse 
spa.  Orthologous sequence was defined by ClustalW alignment (Figure 3.2), although 
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the lack of sequence conservation made it difficult to be certain we were truly swapping 
sequence that was orthologous in any way.  Mutation of any of these regions in D. mel 
spa severely impairs enhancer function, and the replacement of that sequence with D. pse 
sequence was unable to rescue any of these enhancers (Figure 3.3C-E).  A similar 
experiment in which Region 1 of D. mel spa was replaced with the orthologous sequence 
from D. pse spa, on the other hand, did not affect enhancer function (Figure 3.3F).  This 
result was expected based on the high conservation of Region 1 sequence.  We conclude 
that regulatory elements in Region 1 of D. mel spa and D. pse spa are conserved, but 
regulatory elements in D. mel Regions 4, 5, and 6A are not.  It is possible that the D. pse 
enhancer is not directly regulated by the Region 4, 5, and 6A inputs; alternatively, 
compensatory sites for those inputs may have been gained elsewhere in D. pse spa to 
maintain overall enhancer function. 
 
Compensatory evolution and reorganization of elements within D. pse spa 
 
 Our chimeric constructs revealed that many of the regulatory elements within the 
3’ portion of D. mel spa (Regions 4, 5, and 6A) appear to be absent from the 3’ portion of 
D. pse spa.  In order to understand how stabilizing selection has acted to preserve the 
function of D. pse spa, we attempted to identify compensatory elements in that enhancer.  
We performed these experiments in the context of pse5’+mel3’, enabling us to individually 
assess potential redundancy of regulatory elements that reside in Regions 4, 5, and 6A of 


















Figure 3.4.  Differences in organization of regulatory elements between D. mel and D. 
pse spa.  (A) The 5’ half of D. pse spa is insufficient to activate robust gene expression 
on its own.  (B)  pse5’ does not require additional input from Lz/Ets/Su(H) to drive cone 
cell expression at wild-type levels; black boxes represent mutated Lz/Ets/Su(H) sites.  (C)  
However, pse5’ does require additional regulatory input from D. mel Regions 4, 5, and 
6A; black regions have been mutated.  (D)  Mutation of D. mel Region 4 results in a 
severe loss of activity in the context of the pse5’+mel3’ chimera (compare to Figure 3.3B), 
whereas mutation of either Region 5 or Region 6A in that context does not affect the 
activity of the chimeric enhancer (E-F). 
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 Our previous set of experiments suggested that much of the regulatory function of 
D. pse spa was contained within its 5’ half, particularly since the 3’ half of this enhancer 
was not able to complement the 5’ half of D. mel spa at all (Figure 3.3A).  However, the 
5’ half of D. pse spa is not sufficient on its own to activate wild-type levels of gene 
expression (Figure 3.4A).  We then asked whether pse5’ requires contributions from the 
Lz/Ets/Su(H) sites, or from the regulatory elements within Regions 4, 5, and 6A.  
Surprisingly, the 5’ half of D. pse spa requires no additional contribution from the 3’ mel 
Lz/Ets/Su(H) sites to drive wild-type levels of gene expression, despite the fact that 5’ D. 
pse spa contains only a single binding site for each of these proteins (Figure 3.4B).  
However, mutation of the mel sequences outside the Lz, Ets, and Su(H) sites resulted in a 
complete loss of enhancer activity in the context of pse5’+mel3’ (Figure 3.4C).  Clearly, 
pse5’ requires some or all of the sequences in Regions 4, 5, and 6A for proper function.  
Therefore, it seemed likely that these regulatory inputs are indeed conserved in D. pse, 
and compensatory sites for these inputs have evolved in novel locations in D. pse spa.  
Our next set of experiments sought to map the presence of Region 4, 5, and 6A regulatory 
elements in the D. pse spa enhancer. 
 Again in the context of pse5’+mel3’, we made targeted mutations in regions 4, 5, 
and 6A of the mel 3’sequence to determine whether the activities in those regions were 
complemented by regulatory elements in the 5’ half of D. pse spa.  We found that 
mutation of regions 5 or 6A had no effect on gene expression in this chimeric construct, 
indicating that regulatory elements that are functionally equivalent to elements in 5 and 
6A  reside in the 5’ half of D. pse spa (Figure 3.4E-F).  Mutation of Region 4, however, 
resulted in a significant reduction in reporter gene expression (Figure 3.4D).  Therefore, 
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the 5’ half of D. pse spa does not contain sequences that can functionally replace the 
regulatory element within D. mel spa Region 4.  We suspect that this regulatory element 
is in fact conserved in D. pse, but may be located more 3’ to the sequence we considered 
to be the orthologous to D. mel Region 4 in the r4 swap construct; future experiments will 
test this hypothesis.  These data suggest a model in which the TFBS composition of D. 
pse and D. mel spa are conserved overall, but individual TFBS are not conserved.  
Instead, multiple binding site loss and gain events have resulted in two enhancers with 
conserved function but very different TFBS organizations.  
 
Conservation of Regulation by Lz, Ets, and Su(H) 
 
While it appears that the regulatory inputs that control spa are conserved, the 
relative contribution of each of these inputs to enhancer function may not be entirely 
static.  In particular, the relative lack of Lz, Ets, and Su(H) sites in D. pse spa is 
surprising.  We wanted to explore the possible reasons behind differences in the number 
of binding sites for these proteins, in hopes of better understanding the regulatory 
circuitry that governs these two enhancers. 
 The individual requirement for Lz, Notch, and EGFR inputs in regulation of D. 
mel spa has been previously demonstrated (Flores et al, 2000).  However, the sites in D. 
pse spa are putative and have not been tested in vivo.  We mutated these sites in reporter 
constructs to test the direct regulation of D. pse spa by Lz, PntP2/Yan, and Su(H).  
Because our reporter constructs differ in several respects from the constructs used to test 









Figure 3.5.  Both D. mel and D. pse spa require Lz, Ets, and Su(H) binding sites for 
proper transcriptional activation.  (A-C) Binding site mutations in the D. mel spa 
enhancer.  Black boxes represent mutated binding sites.  Mutation of all Lz sites (A) or 
all Ets sites (B) results in a complete loss of enhancer activity.  Mutation of Su(H) sites in 
D. mel spa results in a significant loss of gene expression (C).  (D-F) Binding site 
mutations in the D. pse spa enhancer.  As in D. mel spa, mutation of all Lz sites (D) or all 
Ets sites (E) results in a loss of enhancer activity.  Mutation of the single putative Su(H) 
site in D. pse spa also significantly disrupts enhancer function (F).  A version of D. mel 
spa that contains only the Lz/Ets/Su(H) sites present in D. pse spa fails to activate robust 
gene expression (G).  In this construct, red, blue, and yellow sites are intact binding sites 
of the same sequence as corresponding sites in D. pse spa; green sequences represent 
sites that were mutated to orthologous sequence in D. pse (not predicted to be functional 
binding sites).  (H) Model of D. mel and D. pse spa enhancers.  Both enhancers require 
binding sites for Lz, PntP2/Yan, and Su(H) (blue, yellow, and red), as well as binding 
sites for the regulatory elements that bind in D. mel Regions 1, 4, 5, and 6A (purple, 
orange, green, and pink).  The location of the orange, green, and pink sites has changed in 
D. pse, and there may also be more binding sites for these proteins in D. pse than in D. 
mel spa (for example, three pink sites in D. pse as opposed to only one in D. mel). 
 82 
are located at -846 relative to the promoter rather than directly upstream), we also made 
binding site mutations in our D. mel spa construct for direct comparison with our D. pse 
spa results. 
 We found that, for both species’ enhancers, mutation of either all Lz sites or all 
Ets sites severely diminished enhancer activity, confirming the necessity of direct 
regulatory input from Lz and PntP2/Yan (Figure 3.5A, B, D, and E).  Mutation of all the 
Su(H) sites in either D. mel spa or D. pse spa significantly reduced enhancer function, but 
we observed a higher level of residual enhancer activity than expected (Figure 3.5C and 
F).  In a previous report, eight putative Su(H) sites were mutated, whereas only five were 
mutated in our construct; we chose not to mutate the additional three sites because they 
did not bind Su(H) protein in vitro (Flores et al, 2000).  However, it is possible that the 
weak activation we observe from our mutant enhancers represents residual Su(H) input 
from these weak binding sites.  Alternatively, because Su(H) functions as a repressor in 
the absence of Notch signaling,  the weak expression observed may result from 
derepression in cell types that lack active Notch signaling.  Additional in vivo and  in 
vitro experiments will be performed to explore the role of Su(H) regulation of spa.  
However, it seems clear that Su(H) binding sites contribute to transcriptional activation 
by spa in both D. mel and D. pse. 
 These results confirm that both the D. mel and D. pse spa enhancers require 
binding sites for Lz, PntP2/Yan, and Su(H).  Because D. pse spa has only about half as 
many Lz/Ets/Su(H) sites as D. mel spa, we postulated that perhaps there is redundancy in 
the  D. mel spa sites.  We tested this hypothesis by building a version of D. mel spa that 
contains only the Lz/Ets/Su(H) sites from D. pse spa.  Because it is impossible to identify 
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truly orthologous sites in the two species, we chose the sites most similar in sequence and 
position for preservation in this D. mel TF swap experiment; we also included the 
additional Ets site present at the very 3’ end of D. pse spa in the D. mel TF swap 
construct (a previous report showed the D. mel spa sequence that was replaced with the 
novel D. pse spa Ets site was not necessary for D. mel spa function; Swanson et al, 
2010).  This construct, which is essentially a version of D. mel spa in which half the 
Lz/Ets/Su(H) sites have been mutated, drove gene expression in a weak and diffuse 
pattern (Figure 3.5G) .  This result suggests that additional TFBS in D. mel spa are not 




 It is becoming evident that stabilizing selection acts on many cis-regulatory 
elements to maintain their function despite rapid sequence evolution and binding site 
turnover.  The Drosophila D-Pax2 sparkling enhancer is an excellent example of an 
enhancer in which overall enhancer activity has been preserved despite lack of sequence 
conservation, probably due to compensatory mutations that have occurred in each lineage 
to offset binding site turnover.  We have taken the evolutionary analysis of spa a step 
further by mapping the location of compensatory mutations between D. mel spa and D. 
pse spa.  The characterization of two functionally equivalent yet very divergent 
enhancers provides insight into the evolution of enhancer sequence and organization, as 





 Alignment of the spa enhancer reveals a striking lack of conservation of critical 
regulatory sequences.  While the D. pse and D. mel spa enhancers are regulated by the 
same transcriptional network, the number and organization of individual TFBS has 
changed due to binding site turnover and compensatory mutations.  As a result, D. mel 
spa contains more sites for Lz, PntP2/Yan, and Su(H).  D. pse spa, on the other hand, 
may have gained more binding sites for the unidentified proteins that bind in Regions 4, 
5, and 6A, perhaps to compensate for the absence of additional Lz, Ets, and Su(H) sites. 
 It is possible that certain Lz, PntP2/Yan, and Su(H) sites in the D. mel spa 
enhancer are redundant, and that specific sites could be lost without any impact on 
enhancer function.  Indeed, binding site redundancy is an important aspect of enhancer 
evolution, allowing individual binding site mutations to become fixed because their 
effects are not deleterious (Wittkopp, 2006).  At least one site for each of these TFs is 
present in every species, and it has been shown they are important for both transcriptional 
activation and proper patterning of gene expression in D. mel and D. pse (Flores et al, 
2000; Swanson et al, 2010).  Yet the melanogaster subgroup has a significantly greater 
number of sites for these factors, and our data suggest that those extra sites are not all 
simply redundant (Figures 3.5G and S3.1).  The increased presence of Lz/Ets/Su(H) sites 
seems to be specific to the melanogaster subgroup, and the most parsimonious 
explanation for this observation would be gain of those sites in that lineage.  The 
presence of extra sites in the melanogaster subgroup could reflect changes in the 
signaling pathways or transcription factors themselves in those species. However, we 
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think that is unlikely as the D. pse spa enhancer behaves very similarly to the D. mel spa 
enhancer in a melanogaster background, which strongly suggests conservation of the 
trans environment; also, the protein sequence of all four spa-binding proteins is highly 
conserved between D. mel and D. pse, with very high conservation (≥96%) of DNA-
binding domains (not shown).  An intriguing possibility is that the gain of sites for Lz, 
PntP2/Yan, and Su(H) was necessary to offset absence of other binding sites. 
 Indeed, some of our data suggest that D. pse spa contains more sites for as-yet 
unidentified activators of the sparkling enhancer than D. mel spa.  Some of our chimeric 
constructs drive significantly higher levels of gene expression compared to either 
endogenous enhancer, suggesting an overall increase in activator binding sites in those 
chimeras.  Since this occurs in constructs with fewer characterized Lz/Ets/Su(H) binding 
sites than D. mel spa, the additional activation most likely originates from unmapped 
binding sites.  Importantly, the 5’ half of D. pse harbors binding sites that compensate for 
the loss of mel Regions 5 and 6A, and mutation of those regions in the context of 
pse5’+mel3’ chimera does not even diminish the elevated transcriptional activity of that 
construct (Figures 3.3B and 3.4E-F).  A model in which D. pse 5’ contains more binding 
sites for the Region 5 and Region 6A activators than D. mel Regions 5 and 6A would 
explain the elevated transcriptional activity of the constructs pse5’+mel3’ chimera, 
pse5’+mel3’ (m5abc), and pse5’+mel3’ (m6A)(Figure 3.5H).  In fact, motif analysis has 
identified several conserved motifs in 5’ D. pse that may represent novel binding sites; 
intriguingly, one of these motifs that is present in one copy in D. mel Region 6A is 
present in 3 copies in D. pse 5’ (Figure 3.5H).  The presence of additional, novel sites for 
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the Region 4, 5, and/or 6A activators in D. pse may represent binding site gains that 
compensate for the relative lack of activation from Lz, PntP2, and Su(H). 
 Taken together, multiple binding site gain and loss events have occurred 
throughout the evolution of spa enhancer, resulting in differences in the TFBS 
composition of D. mel spa and D. pse spa.  Although the previously described direct 
regulatory inputs are conserved and that conservation is likely critical for cone-cell 
specific gene expression, variation in the numbers of individual TFBS suggests some 
flexibility in how those proteins regulate transcriptional activation.  Stabilizing selection 
has preserved the function of spa despite binding site turnover by selecting for 
compensatory mutations that maintain overall activation by spa; in D. pseudoobscura, 
this may have been achieved by gain of additional sites for the Region 4/5/6A activators, 
whereas activation in D. melanogaster and the melanogaster subgroup may be maintained 
by an increased number of Lz/Ets/Su(H) sites.   
 
Enhancer structure and organization 
 
 Previous characterization of the D. mel spa enhancer revealed a surprising degree 
of inflexibility; reorganizations of the enhancer often impaired enhancer function or even 
resulted in a change in the cell-type specificity of enhancer activity from cone cells to 
photoreceptors (Swanson et al, 2010).  Therefore the evolutionary changes in spa 
organization came as a surprise to us, suggesting that the architecture is actually more 
flexible than we thought.   
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 The overall size of spa has not changed significantly between mel and pse;  the D. 
mel spa enhancer is 362 bp total, and the D. pse spa enhancer is 409 bp total.  While there 
is a slight expansion in enhancer size in D. pse, consistent with the overall slightly larger 
genome size of D. pse,  there is likely to be evolutionary pressure to maintain a 
compressed enhancer structure (Richards et al 2005),.  The compressed enhancer size 
allows for the conservation of local activating and repressive interactions we suspect 
occur within spa (Swanson et al, 2010).  Examination of those aspects of spa 
organization that are shared between D. mel and D. pse may provide insights into 
important features of spa enhancer structure. 
For example, Lozenge and PntP2 have been shown to physically interact, and can 
act synergistically in the regulation of target genes (Behan et al, 2005).  Perhaps the 
conservation of the closely spaced Lz/Ets sites in the 5’ portion of the enhancer is 
significant.  This 5’ binding site pair is conserved throughout the Sophophora lineage; 
only D. vir and D. moj lack a closely spaced Lz/Ets binding site pair.  Thus closely 
spaced Lz/Ets sites may be an important feature for gene activation in cone cells. 
 Our previous work also identified the presence of an element in D. mel Region 5 
that mediated repression in photoreceptors; that repressive function appeared to be a 
short-range activity, suggesting that its placement within the enhancer is critical for 
proper patterning (Swanson et al, 2010).  Despite the profound organizational differences 
between D. mel and D. pse, D. pse spa does not drive ectopic expression in cell types 
other than cone cells.  Furthermore, none of our chimeric constructs were ectopically 
activated in photoreceptors.  Therefore, none of our constructs disrupt Region 5 repressor 
function.  While we do not know the exact motif to which the repressor binds in D. mel 
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spa Region 5, it is worth noting that that region is flanked by an Ets site and a Lz site.  
The mutation of Region 5 in the context of the pse5’+mel3’ chimeric enhancer did not 
result in ectopic gene expression, suggesting that the repressive function is intact in that 
construct, either somewhere within the 5’ half of pse or elsewhere in the 3’ half of mel.  
Our previous study did note that the repressor site in Region 5 was redundant with a site 
or sites in Regions 2/3/6B; since only region 6B is present in the chimeric context, it is 
possible that a redundant site in 6B is still able to mediate repression in the absence of 
Region 5.  Alternatively, the 5’ half of pse may harbor a site for this repressor, likely in 
pse Region B (Figure 3.5H).  Interestingly, pse Region B is flanked by an Ets site and a 
Su(H) site (Figure 3.5H).  The common presence of a flanking Ets site in both mel 
Region 5 and pse Region B may suggest that the unknown repressor interacts with the Ets 
proteins PntP2 and Yan; this possibility is intriguing because the unknown repressor 
could be influencing either activation or repression by blocking activation by PntP2, or 
by cooperating with Yan to mediate repression. 
 Conserved structural features are difficult to identify in spa because not all critical 
regulatory sequences have been narrowed down to the level of a TFBS.  We expect that 
the identification of novel binding sites and the proteins that bind those sites, perhaps via 
the motif analyses these data have helped us perform, will aid in elucidation of the rules 








Generation of chimeric enhancers and transgenic reporter flies 
 
 Enhancer constructs were built using PCR-based techniques.  Constructs that 
combine D. melanogaster and D. pseudoobscura sequences were generated by overlap 
extension (sewing) PCR using previously described D. mel spa and D. pse spa enhancers 
as templates (Swanson et al, 2010).  Enhancers that contained multiple internal mutations 
were generated by assembly PCR (Swanson et al, 2010).  Binding sites were mutated as 
follows:  Lz sites were converted from RACCRCA to RAAARCA;  Ets sites from 
GGAW to TT
 
AW; and Su(H) sites from YGTGDGAA to YGTGDCAA.  These 
mutations have been shown to eliminate in vitro binding (Bailey and Posakony, 1995; 
Flores et al, 2000).  PCR products were cloned into pENTR/D-TOPO (Invitrogen) and 
then subcloned via Gateway cloning into Ganesh-G1 for injection (Invitrogen, Swanson 
et al, 2008).  Embryos from w1118 flies were injected as described by Rubin and Spradling 
(1982). 
Dissections and Microscopy 
 
 Eye imaginal discs were dissected from transgenic late third-instar larvae and 
fixed in 4% paraformaldehyde for 30 minutes at room temperature.  Endogenous GFP 
expression was visualized using an Olympus BX51 microscope and Olympus DP70 
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digital camera.  At least 5 independent transgenic lines were dissected and analyzed for 
each reporter construct. 
 
DNA Sequence Alignment 
 
 Orthologous Drosophila sparkling sequences were identified by BLAST searches 
on the DroSpeGe website (Gilbert, 2007; http://insects.eugenes.org/species).  The 
alignments in Figures 3.2 and S3.1 were generated on ClustalW using the default settings 
(Chenna et al, 2003; www.ebi.ac.uk/tools/ClustalW).  The alignment in Figure S3.2 was 








Supplemental Figure 3.1.  ClustalW alignment of the sparkling enhancer across all 
twelve sequenced Drosophila species (Chenna et al, 2003).  Putative Lozenge sites are in 
blue, putative Ets sites are in orange (rather than yellow, as in other figures, so that 
sequence is readable), and Suppressor of Hairless sites are in red.  Sequence shaded light 
blue is conserved with D. melanogaster sequence (shaded gray).  Stars mark bases that 






mel   GTATCAAGTAACT-GGGTGCCTAATTGAAAA--AATTTA--CTATGACCGCAAAGCTGTTTCCTGACTATGACATAGTTTTTTTT-GCTTTGG----T------------TGTGGGATGT 98 
sim   GTCTCAAGTAACT-GGGTGCCTAATTGAAAA--AATTTA--CTTCGACCGCAAAGCTGTTTCCTGACTATGACATAGTTTTTTTTTGCTTTTG----TATTTATTTGGTTTGTGGGATGG 111 
sec   GTCTCAAGTAACT-GGGTGCCTAATTGAAAA--AATTTA--CTTCGACCGCAAAGCTGTTTCCTGACTATGACATAGTTTTTTTTTGCTTTTG----TATTTATTTGGTTTGTGGGATGG 111 
yak   GTCTCAAGTAACT-GCGTGCCTAATTGAAAA--AAAAAAA-CTTTGACCGCAAAGCTGTTTCCTGGCTATGACACAGTTCCTTTTGTTTCTTG----TATTTATTTGGTTTGGGTAATGG 112 
ere   GTCTCAAGTAACT-GGGTGCCTAATTGAAAA--AAAATA--CTTTGACCGCAA-GCTGTTTCCTGGCTATGACATAGTTCTTTTTGTTTCTTG----AATTTATTTTGTTCGGGTAATGG 110 
pse   GTCTCAAATAACT-TCGTGTCTAATTGAAAA--AATGCA--TCCTGACCGCAAGGTGTTTTCCTGGCTCTG--ATGGTATTTTTCTTTTGTTG----TTTTTTTTTATTTGTATTGGTGT 109 
per   GTCTCAAATAACT-TCGTGTCTAATTGAAAA--AATGCA--TCCTGACCGCAAGGTGTTTTCCTGGCTCTG--ATGGTATTTTTCTTTTGTTG----TTTTTTTT-ATTTGTATTGGTGT 108 
moj   GTCTCAGGTAACTTACGTGTTTAATTGAAAAA-AACGCAGAGCTCGACCACAAATGCGTTTTTAGTTTCAGTTTCA---ACTCTAGATCGCTGGGATTG-TCAGGTTTTCATTCCGAATC 115 
vir   GTCTCAAGTAACT-ACGTGTTTAATTGAAAAT-AACGCA--GTCCAACCACAAAGGCGGTTTTAGTTTCTGTTCTACTCATCTCGTATTGCCGAGTTTTCTCATTTTGTTTGCTCGAATC 116 
gri   GTCTCAAGTAACT-ACGTGTTTAATTGAAAAA-AACGCA--ATCCAACCACAAACGTGTTTTTTGTTTCTCTGCCATGCATCTCGGATTGC-----TTTCTTGTTTTGTTTGCTTGACGC 111 
ana   GTATCAAGTAACT-TGGAGCCTAATTGAAAA--AAATTA--CTTCGACCACAATGCAGTTTATCCGGACTT-TCCAGTTTTTTTTTAAATTTA-----TTTTATTTGTTTTGGTCAATGG 109 
wil   GTCTCGAATAACT-ACGTGCTTAATTGAAAAAAAAAATGCAATCCAACCGCAAAGGTGTTTTTAGTTTCTCTTGCTCTGGTTTAGCCTTCTTT---CCATTCATTCATTCATTCATCTGC 116 
      ** **   *****   * *  **********  **           *** ***      ** 
 
mel   AAATGGTCATTGGA------------ACTGG-----ACGCTGTCCCTGTCT-----TCTCACTAAGTTAATGA-TCGTACA-ACCTCAAG-ATCTTATTCACATTGAAA-------T--- 183 
sim   AAATGGTCATTCGA------------ACTGG-----ACGCTAGCCCTGTCT-----TCTCACTAAGTTGATGA-TCGTACA-ACCTCAAG-ATCTTATTTACATTCAAA-------T--- 196 
sec   AAATGGTCATTCGA------------ACTGG-----ACGCTAGCCCTGTCT-----TCTCACTAAGTTGATGA-TCGTACA-ACCTCAAG-ATCTTATTTACATTCAAA-------T--- 196 
yak   AAATGGTCATTGGAG-----------ACTGG-----ACCCTGTTCCCGTCT-----TCCCACTAAGTTGATGA-TCGTACA-ACATCAAG-ATCTGATTCACATTCAAA-------T--- 198 
ere   AAATGGTCATTGGAG-----------ACTGG-----ACGCTGTC-------------ATTACTAAATTGATGA-TTGTGCG-ACATCAAG-ATCTGATTCGTATTCAAA-------T--- 188 
pse   TGATGGTCACTGGAGAGGAGAAGTCCACTGGCTCTGGCTGTGGCTCTGTCTCTGCATGCTATTCACATGGTGA-TCAAGCA-ACCTAAAG-CTCTGAATCAGACTCAGA-------T--- 216 
per   TGATGGTCACTGGAGAGGAGAAGTCCACTGGCTCTGGCTGTGGCTCTGTCTCTGCATGCTATTCACATGGTGA-TCAAGCA-ACCTAAAG-CTCTGAATCAGACTCAGA-------T--- 215 
moj   GAAATGCACTTTTCTC--TTTAATCCTCTGCGTTGGTATTGGA-TAAGTGAATGTACACCTGC-AGCTCTACA-G-GTGTGTATCTG-TA-TCTGTATCTGTATCTGTA-------TCTG 220 
vir   AAAATAGAGCTTGATAAGTTTTCTCTAACGTATTGGTATTGGGGTATCTGTATCTGTATCCGCCGGTTGTGGA-TTGCGGGTAACAGGTA-TTATTGTTGGCCTTCACA-------TGCC 227 
gri   GAAATGGTGCTTGGCT--GATAAGTTGGTAT-CTAACGTATGGGTTTGGGTATTCGTATCCGCCGGTTGTGGA-TTGCGGGTA--------TTATTGTAAGCCTTCACA-------TGTC 212 
ana   AGACAGTCACTGGAGA------AACAAGTGG--TCGTTCTTTACATTGTGTAACATGCCAAATGACATTTTGAATCAGATCCACATCA---CTGCGGTGTACATTTCAA-------C--- 208 
wil   TGGTCAGGCCCAGGCGTTTTACTTTTTTTTTGTTTGCGTTTTTCCTTCTTTCATT-TACTTCTTTATTGTTGCTTGATGCGAATAAGGTGGTCACTGAAAGTATCCGCTAGTTGTCTTCT 235 
                                                                         *              * 
 
mel   TGAAGCACTATTGGTG--TACGAT--TA-CAACGCTCAC-ATTA---TCAGGATATA--AAAAAAAGGTGATAGTAATTCAGCAC-GACTT--TGTAACCACAAATATATGGGAACACAG 289  
sim   TGAAGCACAATTGGTG--TACGAT--TA-CAACGCTCAC-ATTA---TAAGGATATA--AAAAAAATGTGATAGTAATCCAGCACCGACTT--TGTTACCACAAATATATGGGAACAAAG 303 
sec   TGAAGCACAATTGGTG--TACGAT--TA-CAACGCTCAC-ATTA---TAAGGATATA--AAAAAAATGTGATAGTAATCCAGCACCGACTT--TGTAACCACAAATATATGGGAACAAAG 303 
yak   TAAAGCACAAATGGTG--TATGAT--TA-CAACGCCCCTTATTA---TCAGGATATATAAAAAAAATATAATAGTAACTCAGCACCGACTC--CGTAACCACAAATGTATGGGAACACAG 308 
ere   TGAAGTACAATTGGTG--TACGAT--TA-CAACGCTCCTTATAA---TCACGATATATAAAAAAA-TGTTATAGTAACTCAGCACCGAATCGGTGTAACCACAAATGTATGGGAACACAG 299 
pse   TAAGAGACAATCAGAGA-TATGATAGTA-TAGATTACATTACAACATTCACGGTA-ACGGAATAGACCTAATAAGGTGGCTGTACAGCGCAAGTGCAAGTCTATAACCACATAAATACGA 333 
per   TAAGAGACAATCAGAGA-TATGATAGTA-TAGATTACATTACAACATTCACGGTA-ACGGAATAGACCTAATAAGGTGGCTGTACAGCGCAAGTGCAAGTCTATAACCACATAAATACGA 332 
moj   TATCTGT--ATCTGAATCTGTATCTGTATCTGTGCATCCGCCGGTTGTG--GGTTGCGG---GCAATATTTTTGTTAGCCTTCACATGGCTATCA-AGCAACCATGGCCAGAGCTCTGGC 332 
vir   TATGAGGCGACCAGAACCAGCGACCAGGCCCAGAAGCCCACTGGTCACTCCGATCATGGTATGCATTACAATTTTGACTTTGTTCTTCTCTCTGGTGGCAACAATAATAAGTGC-CCAAC 346 
gri   TATCAAGCGAACAGAA-------------CAAGAGGCCCACTGGTCACTCAGATCATGGTGTACATTACAATTTTAAGTTTGTTCTT---TAAGGTATCAACTGAAAAAATAGTATTGGC 316 
ana   AGAAGAATATATATAAGATACACA--TAAAAAAGCACCGTATCGTAAGACGGATTAGTAGGTTGAATTAAATAACCACACAATTAGGAATT-GAACTTCGGGCGACCGAAGTTGATATAC 325 
wil   CATAGCAATCTCAATGCCTTGGATTTCGATTCAGAGTCGGAGTCACAATCGGACCACGGTGTGCATTACAATTTCTTGTCGCATTCTCGTT--CTCATTCACATTCACATTCACATTTAC 353 
                                                         *                   * 
     
mel   ATTACTCCGTGAG----TA-CAACGTAAGTCGGGTGAAGCCAGAAACCACAAATCAAGTTGTTTTCCGGTAGCTTAGG 362 
sim   ATTACTCCGTGAG----TA-CAATTTAAGTCGGCTGAAGCCAGAAACCACAAACCAAGTTGTTTTCCGGTAGCTTAGG 376 
sec   ATTACTCCGTGAG----TA-CAACTTAAGTCGGCTGAAGCCAGAAACCACAAATCAAGTTGTTTTCCGGTAGCTTAGG 376 
yak   ATTACTCCGTGAG----TA-CAACTTAAATCAACTGAAGGCAGC------------------------GTACCTTAGG 357 
ere   ATTACTCCATTAG----TA-CAACTTAAATCGAGTGAAGGCAGAAACCACAAATCAAGTTGTTT-CCGGTAGCTTAGG 371 
pse   GCTTACGATTCAG----TA-CTATATAAATCAGGTGAACACCAAAGCCAC-------------------TAAATCTAA 387 
per   GCTTACGATTCAG----TA-CTATATAAATCAGGTGAACACCAAAGCCAC-------------------AAAATCTAA 386 
moj   TAGAGACCAGCGG----CC-TACTCTCAGCTCCATGAGTATGCAT-TACAATTTT-------------GGACTTCGTG 391 
vir   TAC--TCTGGCTG----CC-T-CGCCGAGCAACCTTTACATGCAAACACAAATTC-------------TTTCCAC-TC 402 
gri   AACATCCAGGC------CA-AGCCAATAACCGCATGAATGCAAATCATTTTGCTC-------------TACCGTTCAC 374 
ana   CCTTGCAGTTAGG----TAACAGCCTTAATTATTAGTATGTATATATATCGGATC--------------GTGTATAGT 385 
wil   ATTGGCCTGGCCAATGCCAGGCCCAATAACCACACGAAAACAAAACACTTTG----------------TTATTACAAT 415 






Supplemental Figure 3.2.  BLASTZ alignment of sparkling enhancer sequence taken 
from the UCSC Genome Browser.  Note that D. willistoni, D. virilis, D. mojavensis, and 
D. grimshawi sequences cannot be fully aligned with D. melanogaster sparkling 
sequence.  Putative Lozenge sites are in blue, putative Ets sites are in orange (rather then 
yellow as in other figures, to make sequence readable), and putative Suppressor of 
Hairless sites are in red.  Stars mark bases conserved across all twelve genomes.  
 
 
D. mel  gtatcaagt-aactgggtgcctaattg----aaaaaatttactatgaccgcaaagctgtt--tcctgactatgac-atag 
D. sim  gtctcaagt-aactgggtgcctaattg----aaaaaatttacttcgaccgcaaagctgtt--tcctgactatgac-atag 
D. sec  gtctcaagt-aactgggtgcctaattg----aaaaaatttacttcgaccgcaaagctgtt--tcctgactatgac-atag 
D. yak  gtctcaagt-aactgcgtgcctaattg---aaaaaaaaaaactttgaccgcaaagctgtt--tcctggctatgac-acag 
D. ere  gtctcaagt-aactgggtgcctaattg----aaaaaaaatactttgaccgc-aagctgtt--tcctggctatgac-atag 
D. ana  gtatcaagt-aacttggagcctaattg----aaaaaaattacttcgaccacaatgcagtttatccggacttt----ccag 
D. pse  gtctcaaat-aacttcgtgtctaattg----aaaaaatgcatcctgaccgcaaggtgttt--tcctggctctgatggtat 
D. per  gtctcaaat-aacttcgtgtctaattg----aaaaaatgcatcctgaccgcaaggtgttt--tcctggctctgatggtat 
D. wil  gtctcgaat-aactacgtgcttaattgaaaaaaaaaatgcaatccaaccgcaaaggtgtt--t-------------ttag 
D. vir  gtctcaagt-aactacgtgtttaattg---aaaataacgcagtccaaccacaaaggcggt--tttagtttctgtt-ctac 
D. moj  gtctcaggtaacttacgtgtttaattgaaaaaaa---cgcagagctcgaccacaaatgcgtttttagtttcagtttcaac 
D. gri  gtctcaagt-aactacgtgtttaattg---aaaaaaacgcaatccaaccacaaacgtgtt--ttttgtttctctg-ccat 
        ** **   * *  *  * *  ******    ***      *         *           *               * 
 
D. mel  -ttttttttgctt-t----------------ggtt-gtgggatgtaaatggtcattgg-a------------actg---- 
D. sim  tttttttttgctt-t----tgtatttatttggttt-gtgggatggaaatggtcattcg-a------------actg---- 
D. sec  tttttttttgctt-t----tgtatttatttggttt-gtgggatggaaatggtcattcg-a------------actg---- 
D. yak  ttccttttgtttc-t----tgtatttatttggttt-gggtaatggaaatggtcattgg-ag-----------actg---- 
D. ere  ttctttttgtttc-t----tgaatttattttgttc-gggtaatggaaatggtcattgg-ag-----------actg---- 
D. ana  tttttttttaaat-t----tat-tttatttgtttt-ggtcaatggagacagtcactgg-agaaa------caagtg---- 
D. pse  ttttcttttgttgtt----tttttttatttgtatt-gg----tgttgatggtcactgg-agaggagaagtccactggctc 
D. per  ttttcttttgttg-t----tttttttatttgtatt-gg----tgttgatggtcactgg-agaggagaagtccactggctc 
D. wil  -tttctcttgctc-t----ggtt-------------------------================================ 
D. vir  tcatctcgtattg-ccgagttttctcattttgtttgctcgaatcaaaatag============================= 
D. moj  tctagatcgctgggattgtcaggttttcattccgaatcgaaatgcacttttctctttaatcctctgcgttggt======= 
D. gri  gcatctcggattg-c-----tttcttgttttgtttgcttgacgcgaaatggtgcttgg====================== 
                                    
 
D. mel  -gacgctgtccctgtcttctcactaagt-------taatgatcgtacaacctcaagatctta--ttcacattgaaattga 
D. sim  -gacgctagccctgtcttctcactaagt-------tgatgatcgtacaacctcaagatctta--tttacattcaaattga 
D. sec  -gacgctagccctgtcttctcactaagt-------tgatgatcgtacaacctcaagatctta--tttacattcaaattga 
D. yak  -gaccctgttcccgtcttcccactaagt-------tgatgatcgtacaacatcaagatctga--ttcacattcaaattaa 
D. ere  -gacgctg--------tcattactaaat-------tgatgattgtgcgacatcaagatctga--ttcgtattcaaattga 
D. ana  -gtcgtt--------ctttacattgtgt------------aacatgccaaatgacattttga--atcagatccacatcac 
D. pse  tggctgtggctctgtctctgcatgctattc--acatggtgatcaagcaacctaaagctctga--atcagactcagattaa 
D. per  tggctgtggctctgtctctgcatgctattc--acatggtgatcaagcaacctaaagctctga--atcagactcagattaa 
D. wil  ================================================================================ 
D. vir  ================================================================================ 
D. moj  ================================================================================ 
D. gri  ================================================================================ 
  
 
D. mel  agcactat-----------tggtgtacg----attacaacgctca-cattatcaggatata--aaaaaaaggtg-at-ag 
D. sim  agcacaat-----------tggtgtacg----attacaacgctca-cattataaggatata--aaaaaaatgtg-at-ag 
D. sec  agcacaat-----------tggtgtacg----attacaacgctca-cattataaggatata--aaaaaaatgtg-at-ag 
D. yak  agcacaaa-----------tggtgtatg----attacaacgccccttattatcaggatatataaaaaaaatata-at-ag 
D. ere  agtacaat-----------tggtgtacg----attacaacgctccttataatcacgatatat-aaaaaaatgtt-at-ag 
D. ana  tgc-----------------ggtgtaca----ttt-----------caacagaagaatata--tataagatacacat-aa 
D. pse  gagacaatcagagatatgatagtatagattacattacaacattca-cggtaacggaatagac-ctaataaggtg-gc-tg 
D. per  gagacaatcagagatatgatagtatagattacattacaacattca-cggtaacggaatagac-ctaataaggtg-gc-tg 
D. wil  =================================================tataagagtataa-aaacagaggaa-ataaa 
D. vir  ================================================================================ 
D. moj  ================================================================================ 
D. gri  ================================================================================ 









D. mel  taattcagca------cgactt--tgtaaccacaaatatatgggaacacagattact-ccgtgagtac------aacgta 
D. sim  taatccagcac-----cgactt--tgttaccacaaatatatgggaacaaagattact-ccgtgagtac------aattta 
D. sec  taatccagcac-----cgactt--tgtaaccacaaatatatgggaacaaagattact-ccgtgagtac------aactta 
D. yak  taactcagcac-----cgactc--cgtaaccacaaatgtatgggaacacagattact-ccgtgagtac------aactta 
D. ere  taactcagcac-----cgaatcggtgtaaccacaaatgtatgggaacacagattact-ccattagtac------aactta 
D. ana  aaa---agcac-----cgtatc--------------------gtaagacggatt-------------------------- 
D. pse  ta---cagcgcaagtgcaagtc--tataaccacataaatacgagcttacgattc---------agtac------tatata 
D. per  ta---cagcgcaagtgcaagtc--tataaccacataaatacgagcttacgattc---------agtac------tatata 
D. wil  tagataagctc-----aaa-----tgtaattg-----atatgaacttgtagattcttgcaatgaatacctttttaaacta 
D. vir  ================================================================================ 
D. moj  ================================================================================ 
D. gri  ================================================================================ 
  
 
D. mel  agtcgggtgaagccagaaaccaca-aatcaag--ttgttttccggtagcttagg 
D. sim  agtcggctgaagccagaaaccaca-aaccaag--ttgttttccggtagcttagg 
D. sec  agtcggctgaagccagaaaccaca-aatcaag--ttgttttccggtagcttagg 
D. yak  aatcaactgaaggcagc---------------------------gtaccttagg 
D. ere  aatcgagtgaaggcagaaaccaca-aatcaag--ttg-tttccggtagcttagg 
D. ana  agtaggttgaattaaataaccacacaattaggaattg---------aacttcgg 
D. pse  aatcaggtgaacaccaaagccactaaatctaaaatcagtttccggcttcct--g 
D. per  aatcaggtgaacaccaaagccacaaaatctaaaatcagtttccggcttcct--g 
D. wil  aataagttgaagactcagactcaagagttaag-------------gaaataaag 
D. vir  ====================================================== 
D. moj  ===========================tcaaa--tttaccatagatagtaaaag 
D. gri  ====================================================== 















 During Drosophila eye development, the Notch and EGFR signaling pathways 
are required for the fate specification of all twelve of the unique cells types that comprise 
each individual ommatidium (Voas and Rebay, 2004). These two signaling pathways are 
used repeatedly to determine individual cell fates, and are directly involved in regulating 
expression of many cell-type specific transcription factors that control cell fate 
specification.  Because regulation by Notch and EGFR alone is not sufficient to define 
cell-type specific expression patterns, additional regulatory inputs must be required to 
generate specific outputs.  
 It has been proposed that combinatorial regulation by Notch, EGFR, and locally 
expressed activators and repressors provides sufficient spatial and temporal information 
for cell-type specific expression (Voas and Rebay, 2004).  For example, expression of 
prospero in R7 and the four cone cells is combinatorially regulated by Glass, Sine Oculis, 
Lozenge, the Notch effector Suppressor of Hairless (Su(H)), and the EGFR effectors Yan 
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and PointedP2 (PntP2) (Xu et al, 2000; Hayashi et al, 2008).  This combination of 
regulatory inputs, each of which acts directly on an eye-specific prospero enhancer, is 
suggested to provide the specificity required to activate expression of prospero in R7 and 
the cone cells, but repress its expression in other cells of the eye that experience active 
Notch and EGFR signaling.   
 Similarly, expression of D-Pax2 in the cone cells is regulated by the sparkling 
(spa) enhancer.  The spa enhancer has been shown to contain binding sites for Lz, Su(H), 
and the Ets factors PntP2 and Yan (Flores et al, 2000).  Direct regulation by these three 
inputs – Lz, Notch, and EGFR – was proposed to be sufficient to generate cone-cell 
specific expression of D-Pax2 (Voas and Rebay, 2004).  Additional characterization of 
spa, however, revealed that sequences outside the twelve mapped binding sites for Lz, 
Su(H), and PntP2/Yan are required for enhancer function (Swanson et al, 2010).  
Therefore, Lz, Notch, and EGFR are not sufficient to regulate D-Pax2 expression in the 
cone cells. 
 Mutagenesis experiments identified four regions of spa outside the Lz/Ets/Su(H) 
binding sites that are critical for enhancer function (Swanson et al, 2010).  These regions, 
designated as Regions 1, 4, 5, and 6A, range in size from ~20-40 base pairs.  Targeted 
mutations made within these regions indicated that most of that sequence is functionally 
significant, and given the size of these regions, it is possible that each region harbors one 
or more transcription factor binding sites.  Data suggest that Regions 4 and 6A are 
important for robust transcriptional activation, Region 5 is important for activation in 
cone cells as well as repression in photoreceptors R1 and R6, and Region 1 is dispensable 
for proper patterning but is required for transcriptional activation when the enhancer is 
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located at a distance from the promoter (Swanson et al, 2010).  Because the regulatory 
functions of these regions differ from one another, it seems likely that they are recruiting 
distinct activities to the enhancer.  Therefore, we suspect that Regions 1, 4, 5, and 6A are 
bound by multiple unidentified proteins that directly regulate spa function. 
Although multiple transcription factors are known to be expressed in the eye 
during this stage of development, only a few proteins are good candidates to regulate spa 
based on expression, activator or repressor function, and binding site sequence.  Two 
promising candidates are BarH1/H2 and Sine Oculis.  BarH1 and BarH2 are functionally 
redundant homeodomain proteins expressed in the photoreceptors R1 and R6 and primary 
pigment cells that may act as transcriptional repressors (Higashijima et al, 1992; Reig et 
al, 2007).  There are several putative homeobox binding sites within spa, including two in 
Region 5.  Bar could potentially bind Region 5 to repress spa activity in R1/R6; loss of 
Bar binding to those sites might explain why mutation of Region 5 can, in some contexts, 
lead to derepression of spa in R1 and R6.  Sine Oculis (So) is an activator expressed in 
cells ahead of and behind the morphogenetic furrow in the eye (Serikaku and O’Tousa, 
1994; Pauli et al, 2005).  So may be acting through a putative binding site in Region 1 to 
regulate enhancer activity, although it is unclear whether So could be responsible for the 
long-distance function of Region 1.  We are currently pursuing these and other candidates 
in our lab.  However, we have yet to identify candidates that bind in Regions 4 or 6A, and 
we have not yet determined whether either of our candidates truly regulates D-Pax2 
expression in vivo. 
There are several possible methods to identify novel spa-binding proteins other 
than the candidate approach.  A yeast one-hybrid screen is a classic experimental 
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approach to identify proteins that bind specific DNA sequences.  There are also multiple 
biochemical approaches to isolating and characterizing DNA-binding proteins.  We 
decided to use biochemistry to purify and identify proteins that bind the spa enhancer.  
Our initial biochemistry experiments focused on Region 1 because of its functional 
importance, very high sequence conservation, and possible role in mediating long 




Region 1-specific binding activity in embryonic nuclear extract 
 
 Because we suspect that Region 1 contains at least one novel transcription factor 
binding site, we wanted to test whether nuclear proteins specifically recognized Region 1 
sequences in vitro.  Therefore, we performed gel shift experiments with Region 1 
sequences and embryonic nuclear extract to visualize protein-DNA interactions.  We 
chose to use embryonic nuclear extract for our gel shift experiments because it is feasible 
to obtain enough protein from embryos for biochemical applications, whereas it is 
challenging to isolate large quantities of protein from tissues such as the imaginal discs.  
Furthermore, many proteins expressed in the eye are also expressed in the embryo, 
including Su(H), Lz, Pnt, and Yan (Schweisguth and Posakony, 1992; Scholz et al, 1993; 
Lebestky et al, 2000; Price and Lai, 2000). 
 We found that a wild-type Region 1 probe was consistently bound by a high-


















Figure 4.1.  Embryonic nuclear extract contains a sequence-specific Region 1-binding 
activity.  The wild-type spa Region 1 sequence is shifted by a high molecular-weight 
activity (Lane 2, yellow arrowheads).  Binding of this activity is lost when mutations B 
and C are made to Region 1 sequence (Lanes 7 and 8).  Mutant mB and mC probes also 
fail to compete with the wild-type probe for binding of this activity, suggesting that 
Region 1-binding protein(s) interact specifically with sequences within Regions 1B and 
1C (Lanes 4 and 5). 
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most likely represents a complex of multiple proteins bound to the Region 1 probe 
(Figure 4.1).  This DNA-protein interaction was sequence-specific, because mutations in  
the Region 1 probe could disrupt binding (Figure 4.1).  In particular, mutation of Region 
1B resulted in a complete loss of binding activity, and unlabeled 1B mutant probe was 
unable to compete with the wild-type Region 1 probe for binding of this complex (Figure 
4.1).  These data suggest that a protein complex in embryonic nuclear extract recognizes 
specific sequences in Region 1.  The proteins within this complex may be novel 
regulators of the spa enhancer. 
 
Biochemical purification of potential spa-binding proteins 
 
 We next designed a biochemical approach to purify proteins from embryonic 
nuclear extract that bound specifically to sequences within Region 1.  We used 
biotinylated oligos bound to streptavidin-coated magnetic beads to pull down DNA-
binding proteins from embryonic nuclear extract.  The double-stranded oligos were 
comprised of either the wild-type Region 1 sequence or the 1B mutant sequence; the 1B 
mutant sequence was an appropriate negative control since it was not shifted by 
embryonic nuclear extract in our gel shift experiments.  Comparisons with our negative 
control allowed us to identify proteins that recognized specific sequences within Region 
1. 
 Both the wild-type Region 1 and mutant 1B sequences were bound by multiple 
proteins in embryonic nuclear extract.  Separation of these proteins by SDS-PAGE 













Figure 4.2.  Purification of Region 1-binding proteins.  Region 1 wild-type sequence and 
mutated sequence were used to pull down proteins from embryonic nuclear extract; 
proteins were then eluted from the DNA (which was bound to streptavidin-coated 
Dynabeads) and loaded onto an SDS-PAGE gel.  Examination of the stained gel revealed 
that several bands pulled down by the wild-type probe were unique and were not pulled 
down by the 1mB probe (arrows; top-most band not visible in this image).  These four 
bands were cut directly from the gel and submitted for analysis by mass spectrometry. 
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interactions are non-specific (Figure 4.2).  However, four protein bands were uniquely 
pulled down by the wild-type Region 1 sequence, indicating that those proteins recognize  
specific sequences within Region 1 (Figure 4.2).  These protein bands were cut out from 
the SDS-PAGE gel and identified by mass spectrometry.   
 
Characterization of Region 1-binding proteins 
 
 Mass spectrometry identified six proteins within those unique bands, each of 
which may be a novel regulator of spa based on its ability to bind Region 1 in a 
sequence-specific manner.  These candidates were identified as Aly, Adh Distal Factor-1 
(Adf-1), Pep, Splicing factor 2 (SF2), CG3800, and CG5787.  Two of these proteins, 
CG3800 and CG5787, have not been characterized in Drosophila.  Two others, Aly and 
Adf-1, have identified roles in regulating gene expression.  Adf-1 was originally 
identified as a sequence-specific DNA-binding transcriptional activator of the Alcohol 
dehydrogenase gene in Drosophila; however, no putative Adf-1 binding sites can be 
identified in Region 1 (Heberlein et al, 1985).  The mammalian homolog of Aly has been 
shown to function as a coactivator, while yeast homologs have been implicated in both 
transcription and mRNA export (Bruhn et al, 1997; Strasser and Hurt, 2000; Strasser et 
al, 2002).  The role of Aly in Drosophila has not been fully characterized, although it is 
not absolutely required for mRNA export (Gatfield and Izaurralde, 2002).  The last two 
proteins, Pep and SF2, have no known role in regulating transcription.  Pep is a zinc-
finger RNA-binding protein that has been shown to associate with specific mRNAs in 
hnRNP complexes (Amero et al, 1991; Amero et al, 1993; Hamann and Stratling, 1998).  
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SF2 has been primarily characterized as an essential splicing factor or an alternative 
splicing factor, although intriguingly, overexpression of SF2 in the Drosophila eye 
results in a cone cell phenotype (Ge and Manley, 1990; Krainer et al, 1990; Gabut et al, 
2007). 
 Although none of these proteins is an obvious candidate for regulation of D-Pax2 
expression in the Drosophila eye, we decided to perform preliminary characterization of 
each of these candidates.  First we asked whether any of these proteins were able to bind 
Region 1 sequence specifically in vitro.  All six candidate proteins were expressed from 
full-length cDNAs in an in vitro transcription/translation system.  Two different full-
length cDNAs exist for Pep, and we tested both isoforms.  Expressed proteins were tested 
for their ability to bind a wild-type Region 1 probe and a 1B mutant probe in gel shift 
experiments.  We found that none of these proteins is able to bind specifically to Region 
1 sequence in vitro (Figure 4.3).  However, the lack of ability to directly bind Region 1 
sequence does not immediately rule out any of these candidates.  If these proteins bind 
DNA as part of a complex, individual proteins may not be able to bind Region 1 without 
other members of the complex present.  We did test the ability of the candidate proteins 
to bind Region 1 together, in case the candidates themselves comprise a DNA-binding 
complex, but did not see any shift in the combined presence of all six candidates and 
Region 1 DNA (not shown).  We concluded that none of our candidates can 
independently bind to sequences within Region 1. 
 Because at this point we could not rule out any of the candidates, we proceeded to 
test the requirement for these proteins in vivo.  We obtained UAS-RNAi transgenic flies 









Figure 4.3.  Candidate regulators of spa do not bind Region 1 sequence in vitro.  
Candidate proteins were expressed from full-length cDNAs using a TnT in vitro 
transcription/translation system.  The Region 1 wild-type sequence was bound by 
multiple proteins present in the TnT lysate, presumably non-specifically (Lane 1).  
Presence of expressed proteins did not result in unique shifts of the Region 1 sequence, 
suggesting that none of these proteins directly binds Region 1 in vitro (Lanes 3, 5, 7, 9, 
11, 13, and 15).  Pep LD and SD lanes represent the two different isoforms of Pep that 
were tested.  Mutant 1mB probes were not specifically shifted by any of the candidate 
proteins either (Lanes 4, 6, 8, 10, 12, 14, and 16). 
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GMR-Gal4 transgenic flies with UAS-RNAi transgenic flies; the GMR driver is active in 
all cells behind the morphogenetic furrow of the imaginal eye disc, and therefore  
knockdown of candidate proteins should occur in all cells behind the furrow (Freeman, 
1996).  We assayed knockdown phenotypes in two ways: by antibody staining for the 
cone cell marker Cut, and by examining the eyes of adult flies.  Loss of D-Pax2 
expression would result in loss of cone cell specification, resulting in both loss of Cut 
expression and in a visible eye phenotype in adult flies.  As a positive control, we also 
knocked down expression of D-Pax2.  In D-Pax2 knockdown flies, we observed a loss of 
expression of the cone cell marker Cut in late larval imaginal eye discs, as well as a 
sparkling eye phenotype in the adults (Figure 4.4H, data not shown).  However, none of 
the candidate gene knockdown flies displayed either phenotype (Figure 4.4B-G, data not 
shown).  The presence of GMR-Gal4 in the absence of an RNAi transgene had no effect 
on either Cut expression or eye development (Figure 4.4A, data not shown).  We 
concluded that none of the candidate genes is essential for D-Pax2 expression, and thus 




 The spa enhancer is most likely regulated by additional proteins other than Lz, 
Su(H), PntP2, and Yan, but the identity of those novel regulators remains unknown.  We 
attempted to purify and characterize novel spa-binding proteins using a biochemical 
approach.  Although we were able to isolate proteins based on binding to wild-type 












Figure 4.4.  RNAi knockdown of candidate proteins in the Drosophila eye.  Knockdown 
of candidate proteins was accomplished by crossing GMR-Gal4 flies with UAS-RNAi 
flies; knockdown phenotype was assessed by staining for expression of Cut, a cone cell 
marker.  The presence of the GMR-Gal4 transgene alone does not affect cone cell 
development as assessed by Cut expression (A).  RNAi knockdown of candidate proteins 
did not appear to affect cone cell development (B-G), whereas RNAi knockdown of D-
Pax2, the gene controlled by the spa enhancer, resulted in a loss of Cut staining, 
suggesting a loss of cone cells in the eye (H).   
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Therefore, it seems unlikely that any of these proteins is an important novel regulator of  
D-Pax2 expression in the Drosophila eye. 
 Identification of additional regulators of D-Pax2 expression is still a primary 
objective of our lab.  The biochemistry strategy described here could be improved upon 
before reattempting protein pulldowns with Region 1.  For example, rather than using the 
1B mutant probe, it may be more effective to use a mutant probe in which the entire 
Region 1 sequence has been mutated.  We are also performing pulldown experiments 
with other important regulatory sequences within spa.  In addition, we are pursuing a 
yeast one-hybrid approach to identify spa-binding proteins.  Finally, we continue to 
pursue a candidate approach to identify novel regulators of spa function. 
 Through multiple approaches, we believe we will discover additional direct 
regulators of the spa enhancer.  Identification of additional regulators of spa will not only 
help us understand the specification of cone cell fate in the Drosophila eye, but will also 
allow us to examine protein-protein interactions that occur among regulators of spa and 




Gel shifts with Region 1 sequences 
 
 We purified embryonic nuclear extract from 0-12 hour embryos collected over 
three days.  Purification of embryonic nuclear extract was performed as described 
(Sullivan et al, 2000).  Gel shift probes were simultaneously annealed and labeled by 
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combining 37 µl sdH2O, 5 µl 10X PNK buffer, 1 µl top strand oligo (2 µM), 1 µl bottom 
strand oligo (2 µM), 5 µl γ32P-ATP, and 1 µl T4 PNK (NEB); incubating at 37ºC for one 
hour; boiling at 80ºC for 5 minutes; and allowing to cool slowly to room temperature.  
Labeled probes were purified twice using GE ProbeQuant G-50 spin columns.  Cold 
competitor probes were made by combining 39 µl sdH2O, 5 µl 10X PNK Buffer, 1 µl top 
strand oligo (200 µM), and 1 µl bottom strand oligo (200 µM).  From there they were 
prepared just as labeled probes with the exception that they were not purified.  Probe 
sequences were as follows, with mutated bases in uppercase: 
 
Region 1 wild-type: gtatcaagtaactgggtgcctaattgaaaaaatttactat 
Region 1mA: gGaGcCaTtCactgggtgcctaattgaaaaaatttactat 
Region 1mB: gtatcaagtaacGgTgGgAcGaattgaaaaaatttactat 
Region 1mC: gtatcaagtaactgggtgcctaCtGgCaCaCatttactat 
 
Gel shift reactions included 1 µl labeled probe, 1 µl nuclear extract (approximately 8 µg 
total protein), 1 µl 10X Gel Shift Buffer (0.1 M Tris-HCl pH 7.5, 0.5 M NaCl, 10 mM 
DTT, 10 mM EDTA, 275 µg/ml salmon sperm DNA), 1 µl poly d(I-C) (1 mg/ml), 1 µl 
DTT (100 µM), and 5 µl dH2O.  In reactions that included cold competitor, 1 µl dH2O 
was replaced with 1 µl cold competitor.  Gel shift reactions were incubated on ice for 15 
minutes, then were loaded onto 6% polyacrylamide gels.  Gels were run for 4-5 hours in 




Biochemical purification of Region 1-binding proteins 
 
 The Region 1 wild-type and mB probes used for our pulldown experiments had 
the same sequences as the corresponding gel shift probes.  For pulldowns, top strand 
oligos were biotinylated at the 5’ end.  Double stranded probes were made by combining 
500 pmol biotinylated top strand oligo with 500 pmol bottom strand oligo and adding 
dH2O to final volume of 100 µl, boiling for 5 minutes at 80ºC, then allowing to cool 
slowly to room temperature.   
 100 µl of magnetic, streptavidin-coated Dynabeads (10 mg/ml, Invitrogen) were 
added to a fresh epitube.  Using a magnet, the beads were washed twice with 100 µl 2X 
BW buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 2 M NaCl) and then resuspended in 
100 µl 2X BW buffer.  100 µl probe (500 pmol) was added, and beads and probe were 
incubated for 15 minutes at room temperature on a rotating wheel.  Using a magnet, the 
supernatant was removed and beads, now bound to probe, were washed 3 times in 1X 
BW buffer before resuspension in 50 µl 1X gel shift buffer.  Separately, 35 µl 10X gel 
shift buffer, 35 µl poly d(I-C) (1 mg/ml), 5 µl 0.5 M DTT, 50 µl 7X Roche Complete 
protease inhibitor, 25 µl glycerol, and 150 µl nuclear embryonic extract (approximately 
1.2 mg total protein) were combined.  This mixture was incubated at room temperature 
for 10 minutes, mixing gently every few minutes.  The mixture was then added to the 
resuspended beads and incubated at room temperature for 20 minutes on a rotating wheel.  
Using a magnet, the beads were washed once in 1X gel shift buffer containing 0.1 mg/ml 
poly d(I-C), then washed an additional 3 times in 1X gel shift buffer.  Beads were 
resuspended in 50 µl 1X SDS-PAGE gel loading buffer (50 mM Tris-HCl pH 6.8, 100 
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mM DTT, 2% SDS, 0.1% Bromophenol Blue, 10% glycerol), then boiled for 5 minutes at 
100ºC to elute proteins.  Using a magnet, supernatant (including eluted protein) was 
removed from the beads and loaded onto an SDS-PAGE gel (12% resolving gel, 5% 
stacking gel).  Pulldowns with Region 1 wild-type and Region 1mB probes were 
performed in parallel, with eluted proteins loaded into adjacent lanes on the same gel for 
comparison.  SDS-PAGE gels were run in 1X Tris-Glycine buffer at 120 V for 5-6 hours, 
then stained overnight with Coomassie blue as described (Wong et al, 2000).  Bands of 
interest were cut directly from an SDS-PAGE gel and analyzed using LC-MS/MS by the 
University of Michigan Protein Structure Facility. 
 
In vitro expression of candidate proteins 
 
 Full-length cDNAs for each candidate protein were obtained from the Drosophila 
Genomics Resource Center.  Full-length proteins were expressed from PCR products 
using the TNT ® SP6 High-Yield Wheat Germ Protein Expression System according to 


















Gel shifts with candidate proteins were performed as described above, with the exception 
that these shifts included 3 µl of expressed protein and as a result the water added was 
reduced to 3 µl.  In the shift that included all six candidate proteins, 1 µl of each protein 
and no water was included for that reaction. 
 
RNAi knockdown of candidate protein expression 
 
 Transgenic RNAi fly lines were obtained from the Vienna Drosophila RNAi 
Center.  Gal4 driver lines were obtained from the Bloomington Stock Center.  The GMR-
Gal4 line used here is stock number 1104.  GMR-Gal4 flies were crossed to UAS-RNAi 
flies for in vivo knockdown of protein expression.  Antibody staining was performed 
using a mouse anti-Cut primary antibody from the Developmental Studies Hybridoma 
Bank, diluted 1:50.  Staining and imaging were performed as described previously 










Summary of findings 
 
 Even after thirty years of research, we still do not completely understand the rules 
that govern the function of enhancer elements in vivo.  Our inability to draw general 
conclusions about enhancer structure and function is at least partially due to a lack of 
studies that examine the basic, fundamental aspects of enhancer regulation and 
organization.  Therefore, we performed an in-depth analysis of the Drosophila D-Pax2 
sparkling enhancer to gain further insight into the relationship between structure and 
function in enhancer elements in vivo. 
 The objective of this thesis was to attempt to understand the regulation and 
organization of the spa enhancer.  Our data suggest that both the regulation and 
organization of spa are surprisingly complex.  Previous research had identified three 
direct inputs that regulate spa activity:  the Notch-regulated transcription factor 
Suppressor of Hairless, the EGFR-regulated transcription factors PointedP2 and Yan, and 
the transcriptional activator Lozenge (Flores et al, 2000).  We discovered that in addition 
to the twelve identified binding sites for those proteins, spa harbors essential regulatory 
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elements in multiple sequences that lie outside its characterized binding sites.  It is 
unclear how many additional transcription factor binding sites these novel regulatory 
regions may contain.  However, we have reason to believe that these sequences are bound 
by at least three distinct, unidentified regulators of spa that make individual contributions 
to enhancer function: a regulatory element within Region 1 may be important for long-
range enhancer-promoter interactions, regulatory elements within Regions 4 and 6A are 
important for transcriptional activation, and a regulatory element within Region 5 is 
important for repressing gene expression in photoreceptors.  Taken together, there are at 
least six direct regulatory inputs that bind spa to generate cone cell-specific gene 
expression, although the identity of additional spa-binding proteins remains unknown.  
Our findings reveal an unexpected level of complexity in the combinatorial control of this 
enhancer. 
 We have found that the order and spacing of these regulatory sequences in spa is 
critical to enhancer function.  Changes in spacing between transcription factor binding 
sites can have significant impacts on enhancer activity; we have observed both reduced 
and increased transcriptional responses brought about by altered spacing within spa.  
Therefore, spatial relationships within this enhancer directly impact transcriptional 
output.  The order of transcription factor binding sites within spa also affects enhancer 
function.  Rearrangements of regulatory elements can result in a change in the cell-type 
specificity of gene expression, converting spa from a cone cell enhancer to an R1/R6 
enhancer.  Our data indicate that spatial relationships and local interactions within spa are 
essential not only for activation of transcription, but also for proper patterning of gene 
expression. 
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 However, there is also evidence for flexibility in enhancer structure.  Although 
rearrangements can alter the pattern of gene expression generated by spa, the reorganized 
enhancer is still capable of generating a robust transcriptional response.  Evidence of 
flexibility also comes from our analysis of the evolution of the spa enhancer.  Despite a 
lack of sequence conservation, the function of the spa enhancer is preserved in D. 
pseudoobscura.  Our data suggest that while the overall regulation of D. mel spa and D. 
pse spa is conserved, the exact composition and organization of transcription factor 
binding sites has diverged without changing the function of the enhancer.  We conclude 
that some aspects of spa structure are likely to be quite flexible, while other regulatory 





 Our findings suggest that both the regulation and organization of enhancer 
elements may be more complicated than suspected.  Few enhancer studies go beyond 
identifying obvious transcriptional regulators, mapping their direct binding sites, and 
perhaps testing that those sites are necessary in vivo.  Our data show that this approach is 
likely to overlook important regulatory elements that are critical to enhancer function.  
While it is impractical for every enhancer to be characterized to the extent of our analysis 
of spa, it is sobering to consider that our knowledge of the regulation of most enhancers 
is likely to be incomplete.   
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Even our understanding of spa is incomplete; we have yet to identify all the direct 
regulators of spa, and we still cannot define the precise combination of activating and 
repressive inputs sufficient to activate cone cell-specific gene expression.  Yet this 
research has brought renewed attention to the complicated nature of transcriptional 
regulation.  At least for spa, and perhaps more generally, many regulatory inputs are 
required to generate an appropriate transcriptional response.  In addition, our data suggest 
that a variety of activities must be recruited to properly regulate transcription; in spa, for 
example, simply doubling the number of Lz, Ets, and Su(H) sites cannot compensate for 
the absence of the other regulatory inputs.  Furthermore, some of these regulatory inputs 
may be playing unique roles in regulating gene expression, as does the remote control 
element in Region 1.  In summary, regulation of enhancer function is highly 
combinatorial, in every sense of the word. 
 This analysis has also provided insights into the rules of enhancer organization.  
We have shown that enhancer structure is to some extent flexible, and even a drastically 
rearranged version of spa is able to activate robust gene expression.  Yet there must be 
organizational rules as well, since structural changes can affect the level of transcriptional 
activation and even the patterning of gene expression.  It seems that spa is not as strictly 
structured as an enhanceosome, particularly since over evolutionary time much of the 
sequence and organization of the enhancer has changed without altering function.  
However, spa’s structure is not as flexible as a straightforward information display either.  
Most likely, further characterization of spa will reveal specific synergistic or repressive 
interactions that occur among spa-binding proteins that require particular binding site 
configurations.  We predict that the binding sites for those proteins will be structurally 
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constrained, but binding sites for other proteins can be flexibly rearranged without 
affecting enhancer function.  The identification of novel spa-binding proteins and 
accurate mapping of their binding sites will allow future exploration of these types of 
subelements within spa.  We think it is very likely that this type of organization – overall 
flexibility as long as specific subelement structure is maintained – is common among 
endogenous enhancer elements.   
 A final point to take away from our analysis of spa is that enhancer sequences 
evolve rapidly compared to coding sequences.  Evolution is often used in silico to 
identify cis-regulatory elements, and is sometimes used to draw conclusions about the 
functional relevance of particular sequences within cis-regulatory elements.  It is unclear 
whether spa would have been identified based on sequence conservation alone, but it is 
clear that many essential sequences within spa are not strictly conserved due to sequence 
evolution, compensatory mutation, and binding site turnover.  While evolution is a 
valuable tool for identifying cis-regulatory elements, our data show that conclusions 




 The work described here has raised as many questions as it has answered.  There 
is much left to be learned about spa function, as well as about enhancer elements in 
general. 
 This thesis project has led to the identification of several important regulatory 
elements within the spa enhancer, some of which have potentially novel and exciting 
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roles in enhancer function.  The identification of additional proteins that regulate spa, as 
well as elucidation of the specific sequences they recognize within spa, is an important 
step in understanding this enhancer.  The characterization of novel regulators of spa will 
not only provide insight into cone cell fate specification and combinatorial control of 
gene expression, but also allow us to ask many more questions about enhancer structure 
and function.  Once these proteins are identified, we can investigate the physical 
interactions that occur among spa-binding proteins, which will lead to better 
understanding of the organizational rules within spa.  It will also be interesting to 
characterize the function of novel spa-binding proteins; we can identify the cofactors 
each protein recruits to the enhancer, as well as follow up on potentially novel 
mechanisms of transcriptional regulation, such as the function of the remote control 
element in Region 1.  Finally, we can try to understand the roles that individual proteins 
play in spa function:  Does spa function strictly require this unique combination of 
proteins?  Or are some of these activities replaceable?  How many ways are there to build 
the sparkling enhancer? 
 It is also important to remember that this analysis, although performed entirely in 
vivo, is still artificial in that we used transgenic reporter constructs with a heterologous 
promoter to assay spa function.  This approach is very useful to understand the structure 
and function of the minimal spa enhancer, which contains all the necessary information 
to activate a cone cell-specific expression pattern.  However, transcriptional activation at 
the endogenous D-Pax2 locus is likely to be even more complicated.  For example, 
although we tested spa function at a greater distance from the promoter than is typically 
used in reporter assays, at the endogenous locus spa acts at a distance of 7 kilobases to 
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direct transcriptional activation at the promoter.  We also have yet to make a version of 
spa that drives gene expression from the endogenous D-Pax2 promoter; initial attempts 
using a minimal version of the D-Pax2 promoter were unsuccessful, hinting at another 
level of complexity in spa function.  Finally, the endogenous D-Pax2 locus most likely 
contains other cis-regulatory elements that affect spa function, such as insulators, 
silencers, and other enhancers.  It is even possible that the minimal version of spa used 
for this study does not include all the regulatory sequences that contribute to cone cell-
specific gene expression.  The endogenous spa enhancer may be larger than the fragment 
used here, or additional cone cell-specific regulatory sequences may be distributed 
elsewhere in the D-Pax2 locus.  Our lab is actively exploring these other aspects of spa 
function. 
 In conclusion, our analysis of the spa enhancer has provided valuable insight into 
the complex relationship between structure and function in enhancer elements.  Our data 
suggest that the typical enhancer may be much more crowded with regulatory elements 
than suspected.  In addition, those regulatory elements recruit a variety of activities to the 
enhancer, some of which may be playing unique roles in regulating transcription.  
Finally, the organization of those regulatory elements is critical not only for activating the 
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